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Abstract 
 
The Bacillus subtilis two-component system (TCS) LiaSR responds to environmental stresses 
inducing cell envelope damage. Here, the signal transduction mechanisms of LiaS/R are 
investigated in order to comprehend its uniqueness compared to other TCSs. My results indicate 
that the soluble portion of LiaS autophosphorylates and plays a bifunctional role towards LiaR. 
LiaR undergoes phosphorylation by acetyl phosphate in a time dependent manner. LiaR and its 
mutants bind to distinct regions on the liaSR promoter pre and post-phosphorylation. LiaR function 
is controlled independently by the N and C terminal domains. Characterization of the effector 
domain mutants created based on the homologous protein from Enterococcus faecalis suggested 
that the dimerization interface of LiaR lies on the N-terminal domain. Additionally, signal 
transduction between LiaSR and Staphylococcus aureus VraSR indicated possible in 
vivo interspecies cross-communication. In conclusion, my research provides comprehensive 
analysis of the LiaS/R signal transduction pathways regulating cellular responses in B. subtilis. 
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Chapter 1 :  Introduction to the LiaSR TCS 
1. Two component systems  
Bacterial cells possess various stress signaling systems that sense and respond to specific stimuli, 
allowing them to cope with changing environmental conditions, usually through differential gene 
expression (Bury-Moné et al., 2009). A multitude of stress stimuli can activate various response 
pathways in order to mitigate envelope stress. In bacteria, the three major regulatory mechanisms 
are: one‐ component systems (OCSs), two component systems (TCSs), and alternative sigma 
factors of the extracytoplasmic function (ECF) family (Staroń et al., 2009). The modular design of 
OCSs is simpler than that of TCSs, with the sensory and regulatory domains fused on a single 
polypeptide that might bind to DNA modulating gene expression (Ulrich et al., 2005). TCSs are 
an example of advanced bacterial innovation and have emerged as a result of separation of the 
sensory and responding domains. Most often, such signaling systems are involved in sensing 
stressful settings that can potentially harm the microbial cell. In response, they initiate defensive 
countermeasures via differential expression of target genes involved in stress‐ resistance and other 
downstream responses (Ulrich et al., 2005; Storz & Hengge-Aronis, 2000). 
 Bacteria and cell envelope stress  
Bacterial Gram-positive cell envelopes lack an outer membrane compared to their Gram-negative 
counterparts. The outer membrane possesses a relatively thin layer of peptidoglycan (PG) that 
plays a major role in protecting Gram-negative organisms from environmental stresses by 
providing an additional stabilizing layer around the cell. Gram-positive microorganisms are 
surrounded by thicker layers of peptidoglycan, permitting them to thrive in harsh environments 
and withstand the turgor pressure exerted on the plasma membrane. Lipid II, and its modified 
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forms play an intermediate role in PG synthesis and mediate the attachment of proteins to the 
bacterial cell wall. Interestingly, the lipid molecule ‘flips’ between the cytoplasmic and 
extracellular interfaces of the cell membrane in a dynamic process (referred to as the lipid II cycle) 
ultimately leading to the translocation of the PG precursors which are used for construction of the 
cell wall (Heijenoort, 2007). The lipid II cycle is considered the rate-limiting step of PG polymer 
biosynthesis and is therefore, the subject of intense scrutiny in the development of novel inhibitors 
that target or exploit this process (Nathaniel & Breukink, 2007). It is well established that various 
antibiotics (ramoplanin, mersacidin, vancomycin, telavancin, nisin, epidermin), lantibiotics and 
other glycopeptides bind non-covalently to peptidoglycan lipid intermediates and interfere with 
cell wall formation (Suntharalingam et al., 2009).  
Soil bacteria are the most abundant antibiotic producers (Bérdy, 2005). Antibiotics produced by 
bacteria can be viewed as a means of interspecies competition for survival in complex and densely 
populated soil habitats (D'Costa et al., 2006). In order to compete with other organisms, soil 
bacteria have developed reflex mechanisms that respond to antibiotic threats. These reflex 
mechanisms typically involve signaling systems that sense the potential threat to the microbial cell 
and as a result, respond by activating distinct downstream processes (Storz & Hengge-Aronis, 
2000). The response of the Gram‐ positive soil organism B. subtilis to cell envelope stress (CESR) 
by antibiotics has been studied extensively (Wecke & Mascher, 2011). Moreover, the ‘ESCAPE’ 
(Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter 
baumannii, Pseudomonas aeruginosa and Enterobacter) group of bacteria has been the topic of 
intense investigation during the last decade. Their high multiple-drug resistance (MDR), has 
rendered entire classes of antibiotics ineffective and is threatening to bring an end to the 'antibiotic 
era' (Alanis, 2005). 
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 The bacterial two-component signal transduction model 
TCSs are primarily found in bacteria, playing essential roles in cellular signaling events, cell-to-
cell communication, adaptation to the environment and pathogenesis thus are important for 
survival (Kristin Wuichet, 2012). In pathogenic bacteria, TCSs play a key role in enduring hostile 
conditions, as they are necessary for sensing and responding to environmental stresses. Owing to 
their absence in humans and other mammals, TCS proteins are considered important targets for 
the development of novel antibiotics. The regulatory mechanism triggered by these systems 
typically involves two proteins: a sensor kinase and a response regulator (RR). The integral 
membrane kinase protein, usually gets autophosphorylated (via ATP) at a conserved histidine 
residue (His) and it then transfers the phosphoryl group to a conserved aspartate residue (Asp) on 
the RR. In turn, the regulator binds to specific sequences on the promoter of its target genes and 
modulates their expression. Autophosphorylation of the sensor histidine kinase (HK) and 
phosphotransfer to the cognate RR are considered quintessential steps in the cascade. Transduction 
may be varied or amplified by incorporating additional domains to the already existing components 
and/or by incorporating auxiliary proteins called connector proteins (Belcheva & Golemi-Kotra, 
2008; Casino et al., 2010). RRs are also subject to phosphorylation by other non-cognate sensor 
kinases as well as small molecular phospho-donors such as acetyl phosphate (AcPO4) or 
phosphoamidate (PA) (Manoharan Shankar, 2015).  
An example of a complete and functional TCS would be the DesRK TCS, involved in regulating 
membrane fluidity in B. subtilis. The regulation is mediated by the cold shock-inducible expression 
of the des gene, which encodes fatty acid desaturase (Aguilar et al., 1998). Similarly, the VraSR 
TCS system has demonstrated its contribution to cell-wall PG synthesis, and its involvement in β-
lactam and glycopeptide resistance in S. aureus (Kuroda et al., 2003). To date, 46 genes have been 
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identified to be subject to regulation by the TCS in S. aureus. For example, the murZ locus is 
crucial for PG synthesis whereas the pbp2 and sgtB genes are required for polymerization of PG 
(Gardete et al., 2006). 
 
 
  
 
 
 
Figure 1.1.1 Schematic representation of elements of a two component system 
The red bolt is indicative of an external stress stimulus/stimuli, while P denotes the phosphoryl 
residue being transferred from the Sensory Histidine Kinase to the Response regulator. 
 
 
Besides the typical two-component organization, multistep His–Asp–His–Asp phosphorelay 
systems can be composed of individual phosphotransfer proteins. This modular organization of 
Spo0F has been extensively investigated in the multi-step pathway controlling sporulation in B. 
subtilis (Fabret et al., 1999). 
 
 
P 
HK 
P 
   RR 
Sensory Histidine Kinase Response Regulator 
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 Domain Organization and Sequence Conservation in Bacterial Histidine 
Kinases 
The TCS includes a HK which usually contains a membrane-spanning region, and a carboxy-
terminal domain consisted of approximately 250 amino acids (Pirrung, 1999). Upon receiving a 
stimulus, the HK typically autophosphorylates on a conserved histidine residue. These stimuli may 
represent external environmental conditions such as changes in osmotic pressure (EnvZ/OmpR), 
temperature (DesK/C), small molecules (NarX/Q, CitA/B), antimicrobial agents (PhoQ/P) and 
chemotaxis (CheA/Y) (Aguilar et al., 2001; Möglich et al., 2009). Although the structure of a full-
length membrane-spanning HK has not yet been reported, structural studies of intracellular and 
extracellular sensors have elucidated how these domains bind their ligands. Accordingly, HKs 
form homodimers in order to facilitate autophosphorylation (Capra & Laub, 2012). While the exact 
mechanisms of recognition of RRs by HKs are not fully understood, there have been multiple 
investigations conducted using bioinformatics, protein engineering, and structural studies trying 
to elucidate this interaction (Cheung & Hendrickson, 2010). Many characteristic features such as 
the charge on the aspartate residue and sequence recognition have been identified to be the key 
factors responsible in the interaction of the proteins (Willett et al, 2013). 
All HKs contain two highly conserved domains: a) the dimerization and histidine phosphotransfer 
(DHp) domain harboring the conserved histidine residue (the site of both the autophosphorylation 
and phosphotransfer reactions) and b) the catalytic ATP-binding (CA) domain. HKs may contain 
at least one, and often several, additional domains on the N-terminus. Most kinases also have at 
least one domain between the transmembrane (TM) and DHp domains, with PAS, HAMP, and 
GAF domains being by far the most common. The PAS domain was first discovered in periodic 
circadian proteins, aryl hydrocarbon nuclear translocator proteins, and single-minded proteins.  
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HAMP are present in HKs, adenylate cyclases, methyltransferases, and phosphodiesterases, 
whereas GAF is the main domain in cGMP-specific phosphodiesterases, adenylyl cyclases, and 
formate hydrogenases (Galperin et al., 2001). 
 
Figure 1.1.2 Representation of conserved domains in Histidine Kinases 
 Many of these domains are present in other protein classes. The orange structure shows the 
dimeric sensor interface. Anti-parallel pairs of transmembrane (TM) helices are shown in blue, 
followed by intracellular signal-transducing domains (White rectangle). HAMP, PAS, GAF are 
varying domains. DHp forms a homodimeric anti-parallel four-helical bundle with two helices 
connected by a hairpin loop, consisting of the phosphohistidine residue. Modified from Casino et 
al., 2010 
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Studies have shed light on a unique type of minimalistic membrane-anchored HK called 
intramembrane-sensing HK (IM-HK). The N-terminal ‘input’ domain consists of two TM sensors 
with a very short extracytoplasmic linker. These HKs often recruit accessory proteins as their 
sensors. Comparative genomics analysis has indicated such HKs are widely distributed in Gram-
positive bacteria with a low G+C content (Firmicutes) and respond to cell envelope stress. Within 
B. subtilis LiaS, BceS, and YvcQ are three HKs that share a striking similarity in their domain 
organization with a short sensing domain consisting of two deduced TM helices with an 
extracytoplasmic linker of less than 25 amino acids between them. This structural similarity is 
suggestive of the fact that these IM-HKs sense their stimuli either on or within the membrane 
interface. 
Some HKs stimulate the dephosphorylation of a phosphorylated RR and therefore are deemed 
bifunctional as they possess both kinase and phosphatase activity (Capra & Laub, 2012). 
Occasionally, input signals may favour dephosphorylation over phosphorylation (Raivio & 
Silhavy, 1997). Because the phosphatase reaction and the phosphotransfer step are mechanistically 
distinct, absence of the catalytic histidine in the kinase portion does not always affect the 
phosphatase activity of the later (Bhate et al., 2015). For example, in the CheA/Y TCS, the HK 
(CheA) lacks phosphatase activity towards the RR CheY. However, an independent protein, CheZ, 
is the designated phosphatase for phospho-CheY (Dutta et al., 1999; Perego & Hoch, 1996). Where 
as in the VraSR TCS of S. aureus phosphorylation levels of VraR, are controlled by the interplay 
between the histidine kinase and phosphatase activities of the bifunctional sensor protein VraS 
(Belcheva & Golemi-Kotra, 2008).  
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 Domain Organization and Sequence Conservation in Bacterial Response 
regulator 
RRs within the TCS signaling cascade control a diverse range of cellular processes. Typically, the 
RR receives a phosphoryl group on the aspartate residue in the N-terminal receiver domain, which 
then influences the properties of the C-terminal, DNA-binding domain (West & Stock, 2001) and 
results in a series of conformational changes that ultimately control binding to the DNA (Gao & 
Stock, 2009). Structural characterization of the DNA-binding domains of various response 
regulators has revealed several variations on the common helix-turn-helix (HTH) theme, 
exemplified by the NarL-type, OmpR-type “winged helix,” Spo0A-type, and Fis-like structures 
(Martinez-Hackert & Stock, 1997; Bairoch et al., 2005).  
 
 
 
 
 
 
Figure 1.1.3 A prototypical Response Regulator 
A typical phosphorylation event on the receiver domain (Green Hexagon) mediated by histidine 
kinases or small phospho-donors in vivo. The effector domain (Aqua Octagon) undergoes a 
conformational change which then affects downstream transcriptional events. 
 
Receiver domains exist in a concentration independent equilibrium between the two predominant 
conformations (inactive and active). The inactive conformation is energetically favored for 
P 
Phospho-donors  
HK-P  
 
Receiver Domain Effector Domain 
N-Terminal        C-Terminal 
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unphosphorylated receiver domains and the active conformation is favored for phosphorylated 
receiver domains. However, sometimes receiver domains exist in the active state despite the 
absence of phosphorylation (Volkman et al., 2001; Nohaile et al., 1997). Inter-domain interfaces 
involving receiver domains can potentially influence RR activity in multiple ways. Studies have 
demonstrated that inter-domain interfaces can pose a barrier to RR activation, specifically by 
restricting the conformational dynamics required for phosphorylation by small molecule phospho-
donors (Barbieri et al., 2010). In addition to forming associations with various DNA-binding 
domains, the receiver domain can also function as a stand-alone model (Galperin & Gomelsky, 
2005). 
 Bacillus subtilis 
B. subtilis is a Gram-positive, aerobic, spore-forming soil bacterium. By forming endospores, the 
bacterium can withstand extreme temperatures and dehydration. Bacterial endospores can survive 
without nutrients for a long time and are resistant to UV radiation, desiccation, extreme freezing, 
and most chemical disinfectants (Microbiology, 2017).  B. subtilis also possess a flagellum which 
allows for faster mobility (Technology, 2009). The bacteria are able to function anaerobically in 
the presence of nitrates or glucose (Nakano & Zuber, 1998).  
B. subtilis is typically considered non-pathogenic to humans and it is primarily found on the skin 
and the intestinal tract. However, because its spores are so resistant, the bacterium is easily spread 
and can cause opportunistic infections in humans. For instance, B. subtilis has been linked to liver 
toxicity in humans (Chen et al., 2010; Oggioni et al., 1998). In addition, B. subtilis has been linked 
to bacteremia in hospital patients treated for cancer and hematological disorders. Furthermore, the 
bacterium produces an extracellular toxin (subtilisin) which has been linked to allergies and 
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hypersensitivity reactions in humans. Lastly, this genus is also known to produce diarrheal 
entertoxins which cause food poisoning and are known to contaminate water and food sources 
(Yilmaz et al., 2006; Yassin & Ahmad, 2012).  
Bacillus species of bacteria including B. subtilis, produce a variety of polypeptide antibiotics 
including bacitracin, tyrotricidin and polymaxin to name a few. These antibiotics are mostly 
effective against Gram-positive bacteria. However, bacteria of these species also produce large 
spectrum and anti-fungal antibiotics that are effective against Gram-negative bacteria (Stein, 
2005). 
A close relative of B. subtilis is Bacillus anthracis the etiologic agent of anthrax. Like its relative, 
B. anthracis is also a Gram-positive spore forming bacterium with proven devastating health 
consequences to humans. Inhalation of anthrax spores is typically lethal and its use as a biological 
weapon in bioterrorism has been well documented. This coupled with antibiotic resistance renders 
B. anthracis a potentially important human pathogen (Nicholson et al., 2000; Yassin & Ahmad, 
2012). 
Although B. subtilis is non-pathogenic, one cannot dismiss the possibility that its virulence 
characteristics might increase with time. Also, it is well established that cell-to-cell communication 
and signaling between microorganisms in the wild can influence bacterial behaviour and in 
particular lead to alteration in factors contributing to virulence (Howell et al., 2006). One can 
therefore envision that antibiotic susceptible strains can potentially acquire new resistance 
mechanisms from antibiotic resistant bacteria as a result of interspecies signaling (Ryan & Dow, 
2008). 
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 LiaSR TCS  
The regulatory network of the model organism B. subtilis possesses over 30 HKs and RRs. It also 
comprises of at least two ECF σ factors and four important TCSs dealing with cell envelope stress 
response (CESR) (Cheung & Hendrickson, 2010; Mascher et al., 2003). One such signaling system 
is LiaSR of B. subtilis, which was identified as a result of investigations of the bacitracin stimulon 
(Mascher et al., 2003). LiaSR (formerly YvqCE) also known as lipid II cycle interfering antibiotic 
sensor and response regulator (Mascher, 2006) mainly responds to the presence of cell wall 
antibiotics such as bacitracin, ramoplanin, vancomycin or cationic antimicrobial peptides 
(CAMPs) all of which interfere with the lipid II cycle (Mascher et al., 2004; Pietiäinen et al., 2005). 
LiaSR also responds to detergents, organic solvents (e.g. ethanol, phenol), and nonspecific stimuli 
such as secretion stress, alkaline shock, and filamentous phage infection, albeit to a weaker degree 
(Mascher et al., 2004; Pietiäinen et al., 2005; Petersohn et al., 2001; Tam et al., 2006; Wiegert et 
al., 2001).  The LiaSR is a damage sensing TCS that is responsible for maintaining cell envelope 
integrity under conditions of stress. The lia locus consists of six genes (liaIH-liaGFSR). LiaG is a 
putative membrane-anchored protein, whose expression is believed to be controlled by a weak 
promoter upstream of the liaG locus. Expression of the promoter (PliaSR) is induced by 
phosphorylated LiaR (Jordan Sina, 2006; Mascher, 2006). The LiaSR TCS is functionally and 
genetically linked to a third protein (LiaF) forming a three-component system known as LiaFSR. 
LiaF acts as a strong suppressor of LiaR-dependent gene expression thereby inactivating the TCS 
(Jordan Sina, 2006; Mascher, 2006).  
In‐ depth studies of the transcriptional profile of the homologous system of YvqFEC in B. 
licheniformis, demonstrated strong induction in the presence of bacitracin and to a weaker degree, 
by vancomycin and D‐ cycloserine (Wecke & Mascher, 2011). Growing and isolating deletion 
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mutants for liaF in L. monocytogenes has proven to be difficult indicating uncontrolled HK activity 
of LiaS leading to highly elevated levels of LiaR~P. This lethality is most likely attributed to the 
remodelling of the cellular envelop and the substantial upregulation of membrane-associated and 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1.4 Organization of the liaSR genetic operon in B. subtilis 
A: The lia locus consists of six genes. Grey coloured arrows indicate the promoter upstream of 
liaIH and a putative promoter upstream of liaG. B: Cellular distribution of the Lia proteins. Images 
adopted from (Jordan Sina, 2006). 
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extracytoplasmic proteins (Frederike et al., 2011). Other orthologs of the LiaSR TCS have been 
characterized in the foodborne pathogens Enterococcus species and S. aureus where multi-drug 
resistance is rapidly evolving. Overall the role of the LiaSR TCS has been implicated in acid, 
osmotic, detergent and antibiotic stress responses (Pöntinena et al., 2017; Munita et al., 2014; 
Belcheva & Golemi-Kotra, 2008). Lastly, the physiological role of the LiaFSR system in Listeria 
monocytogenes is presently unclear, since no resistance against inducing compounds has been 
detected (Frederike et al., 2011; Bisicchia et al., 2007). 
 LiaS the Histidine Kinase and LiaR the Response Regulator 
It is proposed that B. subtilis LiaS is an ideal IM-HK that acts as a stimulus sensor in the cytosolic 
portion of the cytoplasmic membrane (Mascher, Margulis et al., 2003). Its second transmembrane 
helix is connected to a cytoplasmic HAMP domain, while the conserved HK core of LiaS contains 
a DHp domain as well as an ATP‐ binding domain. The phosphohistidine residue is located within 
the DHp domain (Toymentseva et al., 2012; Inouye, 2006).  
VraS from S. aureus is a homologous HK involved in sensing cell wall stress and antibiotics 
(Belcheva & Golemi-Kotra, 2008). Remarkably, LiaS from L. monocytogenes causes a repression 
of the LiaSR regulon indicating its bifunctional HK/phosphatase role (Pöntinena et al., 2017). LiaS 
from Streptococcus mutans, has been demonstrated to control a large regulon consisting of 174 
genes involved in biofilm formation and acid tolerance, but it lacks phosphatase activity towards 
its cognate RR (Manoharan Shankar, 2015).   
B. subtilis LiaR is a typical two‐ domain RR protein with a conserved N‐ terminal receiver domain 
that contains an aspartate residue and a variable C‐ terminal DNA‐ binding domain. LiaR belongs 
to the NarL/LuxR family of response regulators, which possesses a characteristic helix‐ turn‐
helix motif responsible for binding to DNA (Galperin M. , 2010). Examination of LiaR from E. 
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faecium, E. faecalis and its homolog from S. aureus, VraR, suggests a remarkable flexibility in its 
quaternary structure. E. faecium LiaR and VraR are largely monomeric and both form dimers upon 
phosphorylation. In contrast, E. faecalis LiaR exists predominately as a dimer that oligomerizes to 
an active tetramer upon phosphorylation in order to mediate the cellular membrane stress responses 
(Davlieva et al., 2016; Davlieva et al., 2015). DNase I footprinting analysis of the promoters for 
all three organisms has revealed additional DNA binding sites (secondary binding sites) following 
phosphorylation.  
 
 
 
 
 
 
 
 
Figure 1.1.5 Crystal structure of the DNA-binding domain of LiaR from Enterococcus 
faecalis (Davlieva et. al, 2015, PDBID: 4WSZ). 
This model represents the binding of the LiaR DNA binding domain to a 22 bp DNA sequence. 
DNA is shown in grey. The red bar represents the interaction surface for the monomers. 
 
Furthermore, the crystal structure of the beryllofluoride-activated LiaR from E. faecium and the 
DNA binding domains of wild-type LiaR from E. faecalis has elucidated the molecular 
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architecture of the dimerization interface and revealed identity of the DNA binding sequence 
(Figure 1.1.5). 
Deletion of liaR in E. faecalis renders the cells susceptible to daptomycin and other antimicrobial 
peptides (Reyes et al., 2014). In group B Streptococcus bacteria, deletion of liaR confers 
susceptibility to cell wall-active antibiotics and antimicrobial peptides (Klinzing et al., 2013) 
suggesting that LiaR is a good target for the development of novel therapeutic agents that would 
effectively target antibiotic resistance. 
 Physiological role of acetyl phosphate in two‐ component signal transduction 
pathways 
Acetyl phosphate is a highly energetic molecule (ΔG° = 43.3 kJ/mol) able to store greater amount 
of energy and can be used as a substrate for the production of ATP via, substrate level 
phosphorylation (Madigan et al., 2003). Acetyl phosphate levels are regulated by first glycolysis 
in order to break down glucose and other carbon sources followed by phosphotransacetylase - 
acetate kinase (Pta‐ AckA) pathway. Accordingly, acetyl phosphate levels are directly correlated 
to the energy state of the cell. For example, when nutrients are abundant and cellular growth is 
exponential, acetyl phosphate levels are high in the cell. Similarly, acetyl phosphate levels are low 
during the stationary growth phase of the cell (nutrients are depleted) (Gueriri et al., 2008). Several 
RR proteins, such as CheY, NRI, PhoB, or OmpR, are able to use acetyl phosphate as the 
phosphoryl group‐ donor in vitro (Howell et al., 2006). Therefore, it has been hypothesized that 
acetyl phosphate may be able to act as a global signal producer in vivo as it is able to phosphorylate 
RRs of TCSs in vitro (Wolfe, 2005).  
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Figure 1.1.6 A schematic of the Pta-AckA pathway that converts acetyl-CoA to acetate and 
LiaSR phosphorelay 
A: A representation of the phosphotransacetylase (Pta) acetate kinase (AckA) pathway that 
converts acetyl-coenzyme A (acetyl-CoA) to acetate via an acetyl phosphate (acetyl ~ P) 
intermediate. Image adapted from (Fredericks, et al., 2006). B: Shows the possible mechanisms by 
which B. subtilis LiaR can get phosphorylated via LiaS or Acetyl phosphate.  
 
RRs that are acetyl phosphate‐ sensitive under physiologically relevant conditions can be divided 
into three major groups: (i) RRs that do not possess a cognate HK (e.g. RssB), (ii) RRs that are 
present in excess of their cognate HK (e.g. OmpR), or (iii) RRs whose cognate HK mainly acts as 
a phosphatase (e.g. RcsB, NRI) (Haijun Xu, 2010). Nonetheless, the in vivo relevance of the 
phosphotransfer reaction is still debated as phosphorylation induced by acetyl phosphate is only 
observed after deletion of the cognate HKs (Wolfe, 2005). 
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 TCS and Drug designing 
Attractive pharmacological targets of TCSs could include but are not limited to: a) the 
autophosphorylation site of the sensor-kinase, b) the physical interphase between the sensor∼P 
and the response regulator (RR), c) the signal transfer of sensor-kinase∼P to RR (phosphotransfer 
or dephosphorylation), and d) the binding of the RR to the regulatory gene promoter (Stock et al., 
1995). It has been reported that oleic acid inhibits the formation of KinA∼P in a concentration-
dependent manner in the presence or absence of the cognate RR KinB (Strauch et al., 1992). 
Interestingly, another natural compound, bromoacetosyringone completely inhibits the expression 
of vir genes required for crown-gall tumour formation in the pathogenic Agrobacterium 
tumefaciens. (Lee et al., 1995; Barret & Hoch, 1998). A multitude of chemicals have also been 
demonstrated to inhibit TCSs in Gram-positive organisms. These include benzoxazines, 
benzimidazoles, bis-phenols, cyclohexenes, trityls, salicylanilides and others (Frechette et al., 
1997; Licata et al., 1998; Macielag et al., 1997). Many of these synthetic chemicals were shown 
to temporarily inhibit growth of vancomycin resistant E. faecium and penicillin-resistant S. 
pneumoniae (Macielag et al., 1997).  
However, the aforementioned natural and chemical agents are generally inhibitory to Gram-
positive bacteria and seem to target the ATP-binding site of histidine protein kinases.  It is 
noteworthy that, at higher concentrations, many of these compounds could potentially affect the 
integrity of the bacterial cell membrane. Since the structure of the cellular membrane in Gram-
negative bacteria is more robust there is a need to discover drugs that are able to permeate these 
cells and specifically attack the TCS. Several known inhibitors are unfortunately very hydrophobic 
and thus not suitable for use as therapeutic agents (Barret & Hoch, 1998; Pawelczyk et al., 2012; 
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Procaccini et al., 2011; Sonja et al., 2012). Nevertheless, hopefully by using the mechanisms and 
techniques used by these inhibitors, it would be easier to decipher ideal target sites on the TCS.  
Because TCSs are ubiquitous in bacteria, interrupting phosphotransfer and cross talk between 
proteins may perhaps disrupt their ability to develop resistance against antibiotics. Offering us the 
potential for developing a new class of antibacterial agents (Bassler, 1999). 
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Chapter 2 : Understanding the Signaling Mechanism in LiaSR Two 
Component System 
1. Aim of the Thesis 
To date, there is very limited information regarding TCSs in B. subtilis (strain 168), particularly 
with respect to the mechanisms of stimulus perception and the actual signaling cascades governing 
cell envelope stress‐ sensing system. Therefore, the main objective of this thesis was to gain 
deeper insight into the underlying molecular/signaling mechanisms governing the LiaSR TCS. We 
hypothesised that the LiaSR TCS behaves identical to other well-characterized, homologous TCSs. 
In order to achieve this, my work focused on the biochemical characterization of the LiaSR system 
in B. subtilis and set out to address three main aspects.  
The first objective aimed at describing and characterizing LiaS with respect to its autokinase and 
phosphatase activity. In addition, the ability of LiaS to phosphorylate its cognate RR, LiaR, was 
investigated. My second objective aimed at: a) investigating whether LiaR is subject to 
phosphorylation by acetyl phosphate in vitro, b) describing the oligomeric state of LiaR and 
determining the reaction rate constant governing the phosphorylation event, c)  determining the 
exact location of the DNA biding sites and the affinity of the binding of LiaR to its target gene 
promoter,  d) determining the nature of the interaction between the receiver and effector domains 
of LiaR, and e) determining the identity of the amino acids involved in maintaining the 
dimerization interface of LiaR by studying the crystal structure of the homologous protein from E. 
faecalis. My third objective aimed at determining whether there is functional cross-talk between 
interspecies TCSs. Accordingly, the ability of LiaSR to cross-talk with its homologous TCS 
VraSR, from S. aureus, was investigated.  
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2. Experimental Procedures 
 Materials and Chemical Reagents 
All chemicals and antibiotics were from Sigma Aldrich (Oakville, Canada) and Thermo-Fisher 
(Whitby, Canada), unless otherwise indicated. Oligonucleotides were ordered from Sigma Aldrich 
(Oakville, Canada). The Escherichia coli strains, NovaBlue and BL21 (DE3), and cloning 
materials were purchased from EMD4 Biosciences (New Jersey, USA) unless otherwise stated. 
The GST-Tag pGEX-4T vector was acquired from GE Health Care (Quebec, Canada). Restriction 
enzymes were either from New England Biolabs (Pickering, Canada) or Thermo-Fisher. 
Chromatography reagents and columns were from GE Health Care (Quebec, Canada). Bacterial 
growth media were from Thermo-Fisher (Whitby, Canada). The γ labelled ATP was purchased 
from Perkin Elmer LAS Canada Inc. (Toronto, Canada). The Pfu Turbo® High Fidelity DNA 
polymerase enzyme was ordered from Agilent Technologies (Mississauga, Canada). The Proteo 
Extract All-in-One Trypsin Digestion Kit was from EMD4 Bioscience was used. Plasmid 
extraction and Gel extraction kits were ordered from Qiagen (Canada). The B. subtilis strain 168 
genome was attained from ATCC (Burlington, Canada).  
 Cloning of the cytosolic portion of LiaS (GST-LiaS) 
 GST-LiaS (GST-LiaSAla126) 
The following primers were used to amplify the DNA sequence that encoded the B. subtilis liaS 
cytoplasmic region (amino acids 126-360): Forward, 5´-CATGGATCCCGATTGGCCAGAGAT 
CTTC-3´ and Reverse, 5´-ACGCCCGGGTTATCAATCAATAATACTCGAATC-3´. The 
primers contained the restriction sites BamHI and SmaI (underlined sequences), respectively. The 
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amplified gene is referred to as liaSAla126. The amplicon (708 bp) was digested and subsequently 
cloned into the corresponding restriction sites of the vector pGEX-4T-1 resulting in liaSAla126 fused 
to the C-terminus of GST tag. The inserted sequence was verified by DNA sequencing at TCAG 
sequencing services (Sick Kids Hospital, Toronto). The verified construct pGEX-4T-1:: liaS Ala126  
(hereon referred to as GST-LiaS) was transformed into E. coli BL21 (DE3). 
 GST-LiaS Arginine 153 (GST-LiaSArg153) 
The nucleic acid sequence of liaS encoding the cytoplasmic histidine kinase domain of LiaS, 
(amino acid residues 153 to 360), was cloned into the pGEX-4T-1vector, for subsequent GST 
affinity purification.  BamHI and SmaI restriction sites (underlined sequences) were incorporated 
in the forward and reverse primers: Forward, 5´- CATGGATCCGCATCCCTCCAGAAACTTTC 
-3´ and Reverse, 5´-ACGCCCGGGTTATCAATCAATAATACTCGAATC-3´. The verified 
(sequenced) construct (hereon referred to as GST-LiaSR153) pGEX-4T-1::liaSR153 was transformed 
into E. coli BL21 (DE3).  
 Mutation of Histidine 159 to Alanine (GST-LiaS H159A) 
Mutagenesis was carried out using Pfu Turbo® DNA polymerase, the pGEX-4T1::liaS Ala126  vector 
and the following primers: Forward, 5´-CCAGAGATCTTGCTGATGCGGTCAG-3´ and 
Reverse, 5´-CTGACCGCATCAGCAAGATCTCTGG-3´.  Successful mutation of the histidine to 
alanine was confirmed by DNA sequencing.  The mutagenized pGEX-4T1::liaSH159A construct 
(hereon referred to as GST-LiaS H159A) was subsequently transformed into E. coli BL21 (DE3) 
for protein expression. 
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 Cloning of LiaR  
Cloning of LiaR was carried out by Dr. Karen Schrecke under the supervision of Dr. Thorsten 
Mascher in Germany by using the same strategy as VraR in Belcheva & Golemi-Kotra, 2008. The 
construct was then brought to our lab in 2009. 
 Mutation of Aspartate 54 to Alanine in LiaR (LiaR D54A) 
Aspartate 54 of LiaR (GAT) was mutated to Alanine (GCC) using Pfu Turbo® DNA polymerase 
and the following primers: Forward, 5′- GATGTCATTTTAATGGCCCTTGTCATGG-3′ and 
Reverse, 5′-CCATGACAAGGGCCATTAAAATGACATC -3′. The pET26b::liaR vector was 
used as the template for site directed mutagenesis. Successful mutation of the aspartate to alanine 
was confirmed by DNA sequencing and the resulting pET26b::liaRD54A construct was used for 
transforming E. coli BL21 (DE3) cells. 
 Cloning of the liaRN gene into an expression plasmid (LiaRN) 
Glycine 131 of LiaR (GGA) was mutated to a stop codon (TGA). For site directed mutagenesis, 
Pfu Turbo® DNA polymerase and the following primers were used: Forward, 5′- 
AAAGTGGCGTGAAAAGTATTATCCAGGCT-3′ and Reverse, 5′- 
AGCCTGGATAATACTTTTCACGCCACTTT -3′. The pET26b::liaR vector was used as the 
template. Successful introduction of a stop codon was verified by DNA sequencing and the 
resulting pET26b::liaRN construct was used for transformation of E. coli BL21 (DE3) cells. 
 Cloning of the liaRC gene into an expression plasmid (LiaRC) 
The cloning strategy for liaRC did not result in the introduction of tags or extra amino acid residues 
and was similar to the strategy employed for cloning of full-length LiaR. The C-terminal domain 
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of liaR, spanning residues 139–211 (sequence was designed by using ExPASy), was amplified 
using pET26b::liaR and the following primers: Forward, 5′- 
ACGCATATGTCAGGTGAAAACGC-3′ and Reverse, 5′- 
ACGAAGCTTCTAATTCACGAGATGATTT-3′ (the restriction sites NdeI and HindIII are 
underlined). The PCR product was digested with HindIII and subsequently ligated into the pET26b 
vector between the MscI and HindIII cloning sites. The resulting construct was used for 
transformation of E. coli NovaBlue. The purified pET26b::liaRC plasmid was then treated with 
NdeI to remove the DNA stretch between NdeI sites. Correct cloning of liaRC was verified by 
DNA sequencing analyses. The ensuing construct was then pET26b::liaRC  transformed into E. 
coli BL21 (DE3) competent cells. 
2.8   Mutation of Threonine 198 to Alanine in LiaR (LiaR T198A), LiaRC (LiaR 
CT198A), LiaR (LiaR V202A), LiaRC (LiaRC V202A) LiaR (LiaR H205A) and 
LiaRC (LiaR C H205A) 
Threonine 198 residue of LiaR (ACG) was mutated to Alanine (GCG), Valine 202 residue of LiaR 
(encoded by GTG) was mutated to Alanine (encoded by GCG) and the Histidine 205 residue of 
LiaR (CAC) was mutated to Alanine (encoded by GCC) on both the full length and C-terminus. 
Site directed mutagenesis was carried out by using pET26b::liaR and pET26b::liaRC as template 
DNA, Pfu Turbo® DNA polymerase and forward and reverse primers (List of Primers in 
Appendix). DNA sequencing was used to verify the successful mutation and the confirmed 
construct was then used to transform E. coli BL21 (DE3) cells competent cells. 
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2.9 Cloning of liaSR promoter in pT7Blue-3 vector 
The amplified gene is referred to as liaSR promoter was amplified using genomic DNA of Bacillus 
subtilis 168 from ATCC. The following forward and reverse primers were used to amplify the 
nucleic acid sequence that encodes the B. subtilis liaSR promoter sequence (PliaSR, -161 to +31): 
Forward 5´- GAAAGGGAAGCAAGTGTTCATCTGTAAAG-3´ and Reverse, 5´- 
TTCATGCAGATCCTCCTTTCGTTTT - 3´. The amplified gene (192 bp) was gel extracted and 
ligated with pT7blue vector. The resulting construct pT7Blue-3::liaSR was introduced into 
NovaBlue cells via transformation. The inserted sequence was confirmed by DNA sequencing. 
2.10 Expression and Purification of Target Proteins 
2.10.1 Protein expression of wild-type GST-LiaS and GST-LiaS H159A.  
Expression of wild-type LiaS and its mutant was carried as follows: An overnight seed culture of 
E. coli BL21 (DE3) hosting the pGEX-4T-1::liaSAla126 plasmid was prepared in 5 ml Luria Bertani 
(LB) media containing 100 μg/ml ampicillin at 37°C. A 500 μl aliquot from the seed culture was 
used to inoculate 350 ml Terrific Broth medium (TB) supplemented with 100 μg/ml ampicillin. 
The growth of bacteria was allowed to continue up to an optical density (OD600 nm) of ~0.6. 
Induction of protein expression was initiated with the addition of 1 mM isopropyl β-D-
thiogalactopyranoside (IPTG) at 17°C for 17 h.  The culture was harvested by centrifugation 
(6300g for 20 min at 4°C) and stored at -80°C.  
Protein was purified using Glutathione Sepharose affinity resin chromatography. The target 
protein was eluted with 10 mM reduced glutathione in 50 mM Tris buffer, pH 8.0. Fractions were 
analysed on a 12.5% SDS-PAGE gel and subsequently concentrated using an Amicon Ultra-10 
kDa concentrator (Millipore, Toronto). Dialysis was carried out overnight (4°C) to exchange the 
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buffer into 50 mM Tris pH 7.4, supplemented with 100 mM KCl and 5 mM MgCl2. The purity of 
protein was assessed by electrophoresis using a 12.5% SDS-PAGE which was then stained with 
Coomassie Blue. Similar growth, expression and purification techniques were used for GST-LiaS 
H159A and GST-LiaS R153. 
2.10.2 Wild-type LiaR, LiaR D54A, LiaR T198A, LiaR V202A, LiaR H205A 
LiaRC, LiaRC T198A, LiaRC V202A and LiaRC H205A 
Expression of wild-type LiaR and its variants was carried out as follows: an overnight seed culture 
of E. coli BL21 (DE3) hosting either pET26b::liaR wild-type or the variant vectors, was prepared 
in 5 ml LB medium, supplemented with 50 μg/ml kanamycin. A 500 µl aliquot from the seed 
culture was used to inoculate 350 ml TB supplemented with 50 μg/ml kanamycin. Cells were 
grown to an optical density (OD600nm) of ~0.6, and protein expression was induced by adding 0.5 
mM IPTG. The cell culture was incubated for 17 hr at 17°C with gentle shaking at 120 rpm. Cells 
were harvested by centrifugation at 6300 g, for 20 min at 4°C and stored at -80oC. 
Purification of LiaR was performed by two steps on a Fast Protein Liquid Chromatography (FPLC) 
(AKTA Purifier 10, GE Health Care) as previously described (Belcheva & Golemi-Kotra, 2008) 
with a few modifications. Briefly, the cell pellet was resuspended in the 50 mM Tris, pH 7.0, 
supplemented with 5 mM MgCl2, and sonicated to liberate soluble proteins. Cell debris was 
removed by centrifugation at 13000 rpm for 1 hr at 4°C. The resulting supernatant was loaded onto 
a DEAE-Sepharose column and the protein was eluted using a linear gradient of 500 mM Tris, pH 
7.0, supplemented with 5 mM MgCl2. The protein containing fractions were examined using a 
15% SDS polyacrylamide gel. LiaR containing fractions were concentrated using an Amicon 
stirred cell (MWCO, 5 kDa). The protein was loaded onto the Heparin-Sepharose column, 
equilibrated with 50 mM Tris, pH 7.0, supplemented with 5 mM MgCl2. The protein was eluted 
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using a linear gradient up to 500 mM Tris, pH 7.0, buffer, supplemented with 5 mM MgCl2. Protein 
containing fractions were analyzed using 15% SDS-PAGE. The fractions containing LiaR were 
combined and concentrated using Amicon centrifugal filter tubes (MWCO 3 kDa). Expression and 
purification of LiaRC wild-type and its variants was carried out in a similar fashion to LiaR full-
length protein.  
2.10.3 LiaRN 
Expression and purification of LiaRN wild-type and its variants was carried out like VraRN in 
Belcheva & Golemi-Kotra, 2008. To briefly state, the cells were grown to an OD600 of 0.6 and 
allowed to express with 0.5 mM IPTG for 17 hrs at 17oC. Purification of the protein was carried 
out using FPLC with DEAE and Size exclusion column (Sephacryl S-200 HiPrep 26-60) after 
sonication and concentration. The concentration of the protein was verified ech time by using 
nanodrop and BSA standards. 
2.10.4 Wild-type GST-VraS and wild-type VraR 
Expression and purification of GST-VraS was carried out very similar to GST-LiaS, the only 
differences were with respect to the induction temperature being 25 oC in comparison to LiaS. The 
purification involved the GST affinity chromatography with the help of 10 mM reduced 
glutathione in 50 mM Tris buffer, pH 8.0. VraR expression was carried out with the same 
parameters as the LiaR protein. Purification was carried out as previously described for LiaR with 
20 mM Tris and 5 mM MgCl2 equilibration buffer, hence allowing for quicker elution of the buffer 
while using FPLC (DEAE and Heparin Sepharose column) (Belcheva & Golemi-Kotra, 2008) 
2.10.5 Wild-type His-VraS  
Bacterial growth and expression of VraS was done as previously described (Uzma Muzamal, 2014) 
with some modifications.  The modifications include sonication buffer 20 mM Sodium phosphate, 
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300 mM NaCl, 20 mM imidazole, pH 7.4, sonication cycle of total 8 minutes, 15 secs on, 30 secs 
rest, at 30% power, 60% pulse. Buffer exchange was performed using dialysis buffer (50 mM Tris, 
50 mM KCl, 5 mM MgCl2, pH 7.4) overnight at 4°C.  
2.11 Circular Dichroism (CD) spectroscopy and Thermal melting of purified 
proteins 
CD measurement of the target proteins were carried out by preparing a protein solution of 20 
µM in an equilibration buffer. The CD spectrum was recorded from 200 to 260 nm using a 
Jasco J-810 instrument (path length of cuvette 0.1 cm). Phosphorylation was carried out using 
acetyl phosphate (50 mM). The buffer contribution was subtracted and the corrected data were 
plotted using Microsoft Excel. Thermal melting curves were acquired for wild-type LiaR, its 
mutants (T198A, V202A and H205A) and LiaRN proteins and have also been shown in Henry Le’s 
undergraduate thesis, 2017 (Le, 2017). Each of the respective proteins (20 µM) were buffer 
exchanged with 50 mM Tris and 5 mM MgCl2 buffer at pH 7.0. The melting spectrum was 
recorded by monitoring the change in CD signal at 222 nm by ramping the temperature from 25 
°C to 90 °C at a rate of 5 °C/min. Buffer correction was performed in order to gauge the melting 
temperature.   
2.12 In vitro Autophosphorylation of GST-LiaS and its variants 
5 µM GST-LiaS was equilibrated in phosphorylation buffer (PB: 50 mM Tris, pH 7.4, 50 mM 
KCl, 5 mM MgCl2) supplemented with 10 mM CaCl2. The reaction was initiated by the addition 
of [γ- 32P]-ATP at 25 °C. The reactions were quenched by the addition of 5X SDS sample buffer 
at various time intervals. Samples were analyzed by 12.5% SDS-PAGE. The gel was incubated on 
a phosphor screen for 2 hr. The screen was scanned using Typhoon Trio+ variable-mode imager. 
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The band intensities were plotted to obtain progress curves. Phosphorylation was quantified by 
using the NIH ImageJ software (Version 1.45s) (Belcheva & Golemi-Kotra, 2008). ATP 
concentrations ranging from 10 µM to 250 µM were used by mixing hot and cold ATP (a 1:9 ratio 
was used).   
We calculated the pseudo first order equation for phosphorylated GST-LiaS, I = A(1-e -kt), where 
I was the average band intensity, k the rate constant, t was the time and A was the proportionality 
constant relating intensity with concentration. 
In addition, a graph of rate versus ATP concentration was also plotted and fitted to the Mechalis-
Menten equation to calculate binding efficiency, Km and catalytic efficiency, kcat (Belcheva & 
Golemi-Kotra, 2008).  
 
Similar experiments were carried out for GST-LiaS H159A and GST-LiaS R153. 
2.13  Phosphotransfer reaction from wild-type GST-LiaS to wild-type LiaR and its 
variants  
Phosphorylation of GST-LiaS was carried out as previously described (Belcheva & Golemi-Kotra, 
2008). Excess [γ-32P] ATP was removed with the use of a desalting column (ZebaTM, Pierce). 
GST-LiaS-phosphate (4 µM) was added to WT-LiaR (20 µM) in the PB buffer. 20 µl reactions 
were carried out at different time intervals and quenched by adding 5 µl of 5X SDS-PAGE sample 
buffer. Samples were loaded onto a 15% SDS-PAGE. The radioactive gels were exposed to a 
phosphor screen (GE Health Care) for 2 hr and imaged using a Typhoon Trio+ variable-mode 
imager (GE Health Care). The radioactive gels were stained with Coomassie Blue dye. The 
 29 
 
phosphor images of the radioactive gels were quantified using the NIH ImageJ software (Version 
1.45s). Similar experiments were conducted for GST-LiaS to LiaR D54A and GST-LiaS to LiaRN.  
2.14  Phosphorylation of LiaR and its variants by the small phosphor-donor, lithium 
potassium acetyl phosphate.   
To investigate phosphorylation of LiaR by small molecule phosphate donors, lithium potassium 
acetyl phosphate was used as previously described (Belcheva & Golemi-Kotra, 2008). Briefly, 
various concentrations of LiaR and its variants were equilibrated in PB 20 buffer (50 mM Tris, pH 
7.4, 50 mM KCl, 20 mM MgCl2) and phosphorylation was initiated by the addition of lithium 
potassium acetyl phosphate to a final concentration of 50 mM. The reaction mixture was incubated 
at 37°C for 1 hr. Phosphorylation experiments on LiaR T198A, V202A and H205A were 
conducted by Henry Le (Le, 2017). 
2.15  Observing change in the oligomeric structure of LiaR and its variants post 
phosphorylation via Native- Poly Acrylamide Gel Electrophoresis (PAGE) 
The oligomerization state of LiaR prior to and following phosphorylation were examined by 
native-PAGE gel electrophoresis. Protein solutions of 10, 20 and 30 μM in PB 20 were 
supplemented with 50 mM acetyl phosphate and incubated for 1 hr at 37°C to facilitate 
phosphorylation of LiaR and its variants. 20 µl aliquots were removed and quenched by adding 
5X native sample buffer. The SDS free native-PAGE gel was run at a voltage of 90 V and the 
internal temperature of the buffer during the gel electrophoresis was maintained at 4°C. The gels 
were stained with Coomassie Blue to visualize the protein bands. LiaRC was analyzed on an acidic 
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native gel to check the protein based on its isoelectric point rather than its molecular weight in its 
native state. 
2.16  Analysis of phosphorylation of the target proteins by small molecule phospho-
donors using Phos-tag TM gel 
The phosphorylated species were separated from unphosphorylated species on 15% Phosphate 
Affinity SDS-PAGE containing Acrylamide-pendant Phos-tag™ AAL-107 (50 µmol/l) as the 
active chemical (Wako chemical USA, Inc., Cedarlane) (Kinoshita,  et al., 2006). From here this 
gel will be referred to as Phos-tag TM gel. Wild-type LiaR, LiaR D54A and LiaRN samples of 20 
μM in phosphorylation buffer (P20B) were supplemented with 50 mM acetyl phosphate and 
incubated for 1 hr at 37°C. 10μl of samples were quenched with 5 X SDS sample buffer at various 
time intervals.   The gels were run at 120 V and stained by Coomassie Blue dye for visualization 
of the separation. Intensities of the phosphorylated species were quantified using ImageJ software 
and averaged. A graph of intensity versus time was plotted and data were fitted to non-linear fitting 
curve using the pseudo first order equation on Erithacus GraFit software (version 5.0.10) and the 
rate of phosphorylation was determined. 
2.17  Identification of LiaR, LiaR D54A and LiaRC by mass spectrometry  
After purifying the proteins, the homogeneity of the protein was determined by Coomassie Blue 
staining of the SDS polyacrylamide gels. The band corresponding to the protein of interest was cut 
from the gel and was subject to in-gel trypsin digestion carried out using the Trypsin Profile IGD 
kits (Sigma). Proteins identities were confirmed by liquid chromatography-mass spectrometry 
(LC-MS/MS) at the Advanced Protein Technology Centre at The Hospital for Sick Children 
(Toronto, Canada). 
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2.18  Sample preparation for mass spectrometry analysis  
The masses of LiaRN and LiaRN-P were analyzed by ESI-MS at Dr. Wilson’s lab (York 
University). 40µM LiaRN was prepared in 50 mM sodium acetate pH 7.0 buffer. Phosphorylated 
sample of 40µM LiaRN was prepared by incubating the protein and 50 mM acetyl phosphate for 1 
hr at 37°C, followed by desalting. 
2.19 Analytical Ultracentrifugation analysis of LiaRN 
Sedimentation equilibrium experiments on LiaRN (MW:14.029 kDa and partial volume/MW 
:0.753) were carried out at the Ultracentrifugation Service Facility in the Department of 
Biochemistry at the University of Toronto by Ms. Elisa Leung. Briefly, 0.25 mg/ml, 0.50 mg/ml 
and 1 mg/ml LiaRN samples were spun at 20000 and 24000 and 28000 rpm at 20o C. Absorbance 
was recorded at 280 nm and 60-Ti Rotor in a Beckman Optima XL- A analytical ultracentrifuge 
was used.  
2.20 DNA binding ability of LiaR and its variants 
2.20.1 Electromobility Shift Assays for wild-type LiaR, LiaRC and LiaR mutants 
(D54A, T198A, V202A and H205A) 
Binding of wild-type LiaR and phosphorylated LiaR to the promoter region of liaSR (PliaSR), was 
assessed by electrophoretic mobility shift assay (EMSA) as described in Belcheva & Golemi-
Kotra, 2008. To perform EMSA experiments, the gel purified liaSR promoter (2 ng/µl) was 5’ end 
labeled with [γ- 32P]-ATP (3000 Ci/mmol) and LiaR (phosphorylated and unphosphorylated) 
samples ranging from 0 to 10 µM concentration. Similar studied were done for LiaR D54A, LiaRC 
and LiaR mutants (T198A, V202A and H205A). 
 32 
 
2.20.2 DNase I footprinting experiments with liaSR promoter for LiaR and its 
variants 
The DNase I footprinting was carried out as previously described with a few changes (Belcheva 
& Golemi-Kotra, 2008). Briefly, the liaSR promoter region spanning -161 to +31 was amplified 
using the following primers Forward 5′- GAAAGGGAAGCAAGTGTTCATCTGTAAAG-3′ and 
Reverse 5′- TTCATGCAGATCCTCCTTTCGTTTT-3′. Prior to amplification, the forward primer 
was 5′ end-labeled with [γ- 32P]-ATP (3000 Ci/mmol) using T4 polynucleotide kinase (NEB). 
The end-labeled and purified DNA (8 ng/µl) was mixed with LiaR/LiaR~P at concentrations 
ranging from 0 to 20 μM. Similar reactions were done for LiaR D54A, and LiaRC.   
2.21 Investigation of cross-communication between LiaSR and VraSR TCS 
2.21.1 Phosphotransfer reaction between GST-LiaS and VraR 
Phosphorylation of GST-LiaS followed by phosphotransfer to VraR was carried out as described 
in Belcheva & Golemi-Kotra, 2008 as well as the method used for LiaS to LiaR phosphotransfer 
experiments. That is using the HK and the RR in a 1:4 ratio with first autophosphorylating the HK 
and then co-incubating the protein with the RR for varying time intervals. Followed by analysing 
the gels using autoradiography and ImageJ (version 1.5) software. 
2.21.2 Phosphotransfer reaction between GST-VraS and LiaR 
Phosphorylation of GST-VraS followed by phosphotransfer to LiaR was carried out as described 
Belcheva & Golemi-Kotra, 2008. 
2.21.3 DNase I footprinting experiments with vraSR promoter for LiaR and VraR 
 33 
 
The DNase I footprinting was carried out as described previously (Belcheva & Golemi-Kotra, 
2008). Briefly, the vraSR promoter region spanning -121 to +150 was amplified using the 
following forward and reverse primers. Prior to amplification, the forward primer was 5′ end-
labeled with [γ- 32P]-ATP (3000 Ci/mmol) using T4 polynucleotide kinase (NEB). The end-
labeled and purified DNA (8 ng/µl) was mixed with LiaR/LiaR~P and VraR/VraR~P  at 
concentrations ranging from 0 to 20 μM.  
2.21.4 Investigation of protein-protein interactions by pull-down assays of GST-LiaS: 
LiaR, GST-VraS: LiaR, GST-LiaS: VraR and GST-LiaS: His-VraS  
Pull down assays ere conducted as describes in Fridman, et al., 2013 with a few modifications. 
Glutathione-Sepharose affinity resin (75 µl) was equilibrated in PB buffer. GST-LiaS was 
incubated with the resin for 30 min at room temperature. The flow-through was collected, and the 
resin was washed with 1 × PB buffer until no protein eluted. At this point, GST-LiaS-bound resin 
was incubated with LiaR with a 1:4 ratio for 30 min at room temperature. Subsequently, the resins 
were washed fifteen times with 200 µl of 1 × PB buffer. The proteins were eluted with 100 µl 
aliquots of 10 mM reduced glutathione in 50 mM Tris (pH 8.0). Flow-through fractions, wash 
fractions, and elution fractions were analyzed by 12.5% SDS-PAGE. In addition, the resin itself 
µwas incubated with the prey proteins LiaR to investigate for non-specific interactions of these 
proteins with resin. A similar protocol was used to investigate the interaction between GST-VraS 
and LiaR (ratio 1:4), GST-LiaS and VraR and GST-LiaS (ratio 1:4). In the case of GST-LiaS and 
His-VraS, His –VraS was also immobilized onto Ni-NTA agarose resin, and GST-LiaS was added. 
The elution fractions were collected using 100 µl 500 mM Sodium phosphate, 300 mM NaCl, 300 
mM imidazole, and pH 7.4 for 5 min each time and then analyzed by 15% SDS-PAGE (Uzma 
Muzamal, 2014). 
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3 Results 
3.1 Cloning, Expression and purification of proteins 
3.1.1 GST-LiaS 
Initially, the B. subtilis (strain 168) full-length liaS gene had been cloned into a pGEX-4T1 vector 
but protein expression was not optimal due to solubility issues. In order to circumvent this, the 
cytosolic domain of LiaS (residues126-360) was amplified from the pre-cloned liaS full-length 
gene and fused at the COOH-terminus of GST in the pGEX-4T-1 vector (GST-LiaS). An 
additional construct (residues 153-360) was also fused with the GST tag in the pGEX4T-1 vector 
(GST-LiaSArg153). 
Induction of protein expression was attempted at various temperatures and concentrations of IPTG 
in order to maximize the production of soluble protein. Optimal expression was achieved by 
induction with 1 mM IPTG for 17 hr at 17 °C. Purification of GST-LiaS (theoretical molecular 
weight of 52431 Da) was carried out with the use of Glutathione Sepharose 4B affinity resin. We 
tried using PBS buffer as well as a range of pH levels in order to optimize protein yield and purity 
(Figure 2.1.1). Use of GST-LiaSArg153 was discontinued after a few initial experiments, as GST-
LiaS (residues126-360) yielded higher phosphorylation (band intensity with radiolabelled ATP) 
in comparison and consisted of the longer sequence altogether. 
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Figure 2.1.1 GST-LiaS purification with glutathione resin 
12.5% SDS-PAGE analysis of fractions collected during purification. Lane S (supernatant); Lane 
P, (cell pellet following sonication); Lane UB (unbound protein); Lane W12 (fraction collected 
following 12 washes with sonication buffer); Lanes E1 to E5 represent fractions collected during 
elution with 10 mM reduced glutathione in 50 mM Tris (pH 8.0).  
 
3.1.2 GST-LiaS H159A 
To verify the importance of the histidine residue for autophosphorylation, site directed 
mutagenesis was carried out. The phosphohistidine (159th residue) was mutated to an alanine.  The 
overexpression and the purification of the protein was carried out as previously described (section 
3.1.1). The supernatant, pellet and elution fractions containing the protein were analyzed on a 
12.5% SDS gel, as seen in Figure 2.1.2.  GST-VraS, and His-VraS have previously been cloned 
in the laboratory (Belcheva & Golemi-Kotra, 2008; Uzma Muzamal, 2014) 
 
 
 
  S        P     UB  W12   E1   E2    E3    E4    E5 
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Figure 2.1.2 GST-LiaSH159A purification with glutathione resin 
12.5% SDS-PAGE analysis of fractions collected during purification. Lane S (supernatant); Lane 
P, (cell pellet following sonication); Lane W12 (fraction collected following 12 washes with 
sonication buffer); Lanes E1 to E4 represent fractions collected during elution with 10 mM reduced 
glutathione in 50 mM Tris (pH 8.0).  
 
3.1.3 WT-LiaR, LiaR D54A, Li aR T198A, LiaRV202A and LiaR H205A  
LiaR mutants (LiaR D54A, LiaR T198A, LiaRV202A and LiaR H205A) were all generated by 
mutating the full-length wild-type gene, using site directed mutagenesis. Growth and expression 
of all mutant strains was carried out under identical conditions to those used for the wild-type. 
Optimal expression was achieved by inoculating a single colony and adding 0.5 mM IPTG for 17 
hr at 17°C.  The calculated molecular weight of LiaR was determined to equal 23124.76 Da with 
a theoretical pI of 5.13. The mutations did not have an effect on either the molecular weight or pI 
of the proteins as compared to those of the wild-type. Wild-type VraR was previously cloned in 
the laboratory (Antonetta Belcheva, 2009).  
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Figure 2.1.3 Purification of wild-type full-length LiaR and its mutants using FPLC 
A: FPLC UV (280 nm)-chromatogram showing proteins eluted from a Diethylaminomethyl 
(DEAE) Sepharose column and the fractions selected for further analysis. B: 15% SDS-PAGE of 
fractions 37 to 45. Lane 1 represents the supernatant collected following cell lysis. C: FPLC UV 
(280 nm)-chromatogram of the eluted proteins from a heparin sepharose column. The fractions 
selected for further analysis by SDS-PAGE are shown. D: 15% SDS-PAGE of different fractions 
collected from the heparin sepharose column. Lane 1 represents the supernatant prior to the heparin 
column elution, while lanes 2-9 represent fractions 43-53 corresponding to the peak observed on 
the chromatogram.  
 
Purification of WT-LiaR and its mutants was carried out using FPLC at 4°C. A DEAE column 
was used to elute the protein based on charge. As shown in the chromatogram in Figure 2.1.3 A, 
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the resulting fractions were analyzed using a 15% SDS-PAGE (Figure 2.1.3. B). Subsequent step 
of purification was carried out by keeping in mind the properties of a transcriptional regulatory 
protein that binds to the DNA. Heparin-Sepharose formulation exhibits excellent binding capacity 
for proteins due to its similar structure to the DNA backbone. LiaR was eluted from the heparin 
column at a 40-60% concentration of the elution buffer (Figure 2.1.3 C). Analysis of the elution 
fractions by electrophoresis (Figure 2.1.3 D) indicated that the purified protein contained some 
impurities despite using a wide range of experimental protocols. 
3.1.4 C-terminal LiaR and its mutants (LiaRC T198A, LiaRC V202A, LiaRC H205A) 
The calculated theoretical weight and the pI of the C-terminal domain of LiaR was determined to 
be 7466.58 Da and 7.09 respectively. The mutations {(T198A: MW-7436.56 Da; pI- 7.09), 
(V202A: MW-7438.53 Da; pI- 7.09) and (H205A: MW-7400.52 Da; pI- 7.03)} did not cause a 
major change in the molecular weight or pI of the resulting proteins compared to the wild-type C-
Terminal LiaR by using ExPASy ProtParam for the theoretical estimation.  
Purification of WT-LiaRC was carried out at 4°C using DEAE and Heparin Sepharose columns. 
The overall concentration and yield of purified protein was almost half compared to full-length 
WT-LiaR, with a few contaminants present, as indicated in Figure 2.1.4. This could potentially be 
attributed to the fact that the actual pI of the proteins was in fact much higher than the predicted 
values. Accordingly, a range of pH values ranging from 7.0 to 9.0 was tested for the buffers in 
order to maximize the purity of the isolated proteins.  The purity and stability was highest at a pH 
of 8.5 (Figure 2.1.4).  
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Figure 2.1.4 Purification of WT-LiaRC and its mutants using FPLC 
A: FPLC UV (280 nm)-chromatogram showing proteins eluted from a DEAE Sepharose column 
and the fractions selected for further analysis. B: 20% SDS-PAGE of fractions 35 to 49. Lane 1 
represents the supernatant collected following sonication of cells. C: FPLC UV (280 nm)-
chromatogram of the eluted proteins from the Heparin sepharose column. The fractions selected 
for further analysis by SDS-PAGE are indicated. D: 20% SDS-PAGE of different fractions 
collected from the Heparin sepharose column. Lane 1 represents the supernatant after sonication, 
while lanes 2-9 represent fractions 43-53 corresponding to the peak observed on the 
chromatogram.  
 
3.1.5  N-terminal LiaR 
The receiver domain, LiaRN was analysed separately by introducing a stop codon on the 131st 
residue. LiaRN was purified at 4 °C using FPLC, the cellular lysate was first passed through a 
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DEAE column and the resulting fractions were verified using SDS-PAGE. Subsequently, the 
fractions were concentrated and loaded onto a size exclusion column (Sephacryl S-200 HiPrep 26-
60) as opposed to a heparin column because the protein lacked the DNA binding domain. The 
calculated molecular weight of N-terminal LiaR was determined to equal 14029.27 Da with a 
theoretical pI of 4.38. The isolated target protein was homogeneous as seen on Figure 2.1.5. 
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Figure 2.1.5 Purification of wild-type N-terminal LiaR using FPLC 
A: FPLC UV (280 nm)-chromatogram displaying proteins eluted from a DEAE Sepharose column 
and the fractions selected for further analysis. B: 20% SDS-PAGE of fractions 35 to 43. Lane 1 
represents the supernatant collected following sonication. C: FPLC UV (280 nm)-chromatogram 
of the eluted proteins from the Sephacryl S-200 HiPrep column. The fractions selected for further 
analysis by SDS-PAGE are indicated. D: 20% SDS-PAGE of various fractions collected from the 
size exclusion column. Lane 1 represents the supernatant obtained following sonication, while 
lanes 3-10 represent fractions 13-34 corresponding to the peak observed on the chromatogram.  
 
 LiaR N terminal Oct 24th001:10_UV1_280nm  LiaR N terminal Oct 24th001:10_Cond  LiaR N terminal Oct 24th001:10_Cond%
 LiaR N terminal Oct 24th001:10_Conc  LiaR N terminal Oct 24th001:10_pH  LiaR N terminal Oct 24th001:10_Fractions
   0
 500
1000
1500
2000
2500
mAU
   0  200  400  600  800 1000 1200 ml
1 3 5 7 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 54 57 60 63 66 69 72 75 78 Waste
LiaRN 
 LiaR N term Oct 25th001:10_UV1_280nm  LiaR N term Oct 25th001:10_Cond  LiaR N term Oct 25th001:10_Cond%
 LiaR N term Oct 25th001:10_Conc  LiaR N term Oct 25th001:10_pH  LiaR N term Oct 25th001:10_Fractions
-150
-100
-50
  0
 50
100
mAU
  0 100 200 300 400 ml
1 2 3 4 5 6 7 8 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 41 43 45 47 49 51 53 55 57 59 61 63 65 67 69 71 73 75 77 79 81 83 85 87 89 91 93 95
S   35   36   37  39   40   41   42   43 
A 
B 
Fractions 
 S        13   15  23 28  31  32  34 
Fractions 
D 
C 
 42 
 
3.2 Circular Dichroism and thermal melting curves of the isolated proteins  
Circular dichroism (CD) is an important tool used for analysis of the structural properties of 
proteins. This technique is based on the principal that optically active biomolecules, including 
proteins, reveal different absorption of left and right circularly polarized light over a range of 
wavelengths (200-260nm). Here, CD was used for analyzing proper folding of the purified 
proteins. The thermal melting (TM) spectrum was recorded by monitoring the change in CD signal 
at 222 nm by ramping the temperature from 25 °C to 90 °C at a rate of 5 °C /min. The CD spectrum 
suggested that GST-LiaS has a stronger α-helical component, indicated by the negative absorbance 
near 210 nm and 220 nm. Mutation of the histidine residue demonstrated a slight variation in 
secondary structure with respect to α-helices and β-sheets. The CD spectrum of LiaR and its mutant 
LiaR D54A and LiaRC all resembled that of a well folded protein with similar CD spectrums to 
other DNA binding proteins (helix-turn-helix motif). Similar studies were conducted on LiaR 
T198A, LiaR V202A and LiaR H205A (Le, 2017). However, the observed CD spectrum of the N 
terminal of LiaR was different in comparison to its full-length protein (Figures 2.1.6 A and B). In 
addition, phosphorylation-induced conformational changes were further confirmed by CD for the 
wild-type protein and all full-length mutants (LiaR T198A, LiaR V202A, LiaR H205A) (Figure 
2.1.7). These results were similar to a study done on VraR by Belcheva & Golemi-Kotra, 2008. In 
addition, structural analysis was carried out using thermal melting. The melting temperature of 
LiaRN was rather unique in comparison to the classical two step mode seen in full-length protein 
or its mutants (Figure 2.1.8).  
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Figure 2.1.6 The CD spectrum (200-260nm) of the purified proteins (Data shown from Le, 
2017 and used with permission) 
A: Displays the CD spectrum corresponding to GST-LiaS and GST-LiaS H159A indicating no 
substantial changes in secondary structure B: Displays of the spectrum corresponding to WT-LiaR 
and its variants. The N-terminus is structurally different from the wild-type full-length protein and 
the mutants.  
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Table 1: Analysis of the secondary structure component of LiaS Wild-Type and its mutant, 
in WT-LiaR and its mutants when analysed using CD analysis and plotting Tool (CAPITO).  
CD spectra of all proteins (30µM) were first plotted on Excel indicating folding pattern. 
Protein 
α-Helical 
component 
β-Strand 
component 
Irregular coils 
LiaS Wild-Type  16% 30% 54% 
LiaS H159A 16% 30% 54% 
LiaR Wild-Type 7% 44% 49% 
Phosphorylated LiaR Wild-Type 9% 41% 49% 
LiaR T198A 7% 44% 49% 
Phosphorylated T198AA 8% 41% 51% 
LiaR V202A 7% 44% 49% 
Phosphorylated V202A 7% 44% 49% 
LiaR H205A 7% 44% 49% 
Phosphorylated H205A 10% 41% 49% 
LiaR N 15% 29% 55% 
LiaR C 7% 45% 48% 
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Figure 2.1.7 Thermal melting curve for LiaR and its variants (Data shown from Le, 2017 
and used with permission) 
Thermal melting curves of wild-type full-length LiaR, N-terminal LiaR and mutants (10 µM) 
acquired by monitoring the change in ellipticity at 222 nM by ramping the temperature from 25 
°C to 90 °C at a rate of 5 °C/min in equilibration buffer, pH 7.0 
 
3.3 In vitro Autophosphorylation of GST-LiaS and LiaS H159A  
Studies of several HKs have demonstrated that autophosphorylation is involved in the regulation 
of catalytic activity and signaling in vivo. Autophosphorylation of GST-LiaS in the presence of [γ 
- 32P]-ATP at room temperature, indicated a progressive increase in phosphorylation with 
maximal saturation at 60 min. The rate of phosphorylation of GST-LiaS was determined for a 
concentration of ATP ranging from 5 mM to 250 mM (Figure 2.1.10). Km and Vmax values were 
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calculated using the GraFit software (Km of 3.3186 ± 0.7006 µM and Vmax of 0.0667 ± 0.0032 s
-
1) for ATP concentrations ranging from 5 µM to 25 µM and were based on the Mechalis Menten 
equation (Figure 2.1.9). Such a low Km value would mean that the in vivo ATP requirements for 
the system are rather low. As expected the mutation of the phosphohistidine residue at position 
159 abolished the kinase activity of the protein (Figure 2.1.10). These results are indicative of the 
key role played by the histidine residue in autophosphoryation and hence making it one of plausible 
the drug target sites 
 
 
 
 
 
Figure 2.1.8 In vitro autophosphorylation of GST-LiaS using radioactive ATP 
A: Autophosphorylation of 5 µM GST-LiaS in the presence of [γ - 32P]-ATP indicates a 
progressive increase in phosphorylation saturating over a span of 60 min. 10 µl samples were 
quenched with 5X SDS dye every 10 min B: GST-LiaS mixed with [γ - 32P]-ATP. 10 µl samples 
were quenched with 5X SDS dye every 10 min and loaded onto a 12.5% SDS-PAGE, stained with 
Coomassie Blue, to ensure equal loading.  
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Figure 2.1.9 Band intensity of phosphorylated GST-LiaS quantified using ImageJ and 
plotted against time. The data were fitted using GraFit software to pseudo first order 
equation to calculate rate constant. 
Progress curve of autophosphorylation reaction. The quantified band intensities of 
phosphorylation were plotted against time and the standard deviation represented as errors is 
averaged over three different trials. 
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Figure 2.1.10 In vitro autophosphorylation of GST-LiaS H159A using radioactive ATP  
A: Autophosphorylation of 5 µM wild-type GST-LiaS in the presence of [γ - 32P]-ATP. GST-LiaS 
H159A demonstrates lack of phosphorylation over a span of 60 min (phosphor image of 12.5% 
SDS-PAGE). B: 12.5% SDS-PAGE from same trial, stained with Coomassie Blue displaying equal 
protein loading. 
 
3.4 Phosphotransfer reaction from GST LiaS to WT-LiaR and its variants (LiaR 
D54A and LiaRN) 
In vitro phosphotransfer occurs when a radioactively labelled group is transferred from the HK to 
the RR. Having established the autokinase activity of GST-LiaS, its ability to transfer phosphoryl 
groups inter molecularly to its cognate RR, LiaR was examined. Figure 2.1.11 demonstrates that 
GST-LiaS is capable of transferring a phosphoryl group to LiaR. It was observed that almost 50% 
of the phosphate associated with GST-LiaS was transferred to the RR within the first 30 secs. The 
estimated pseudo first order rate constant for the phosphotransfer reaction was 0.0609 ± 0.0288 s-
1. Past 1 minute, the signal for LiaR begins to fade. This is most likely attributed to the phosphatase 
GST-LiaS        GST-LiaS H159A 
1’    30’     60’     1’      30’     60’    
 
A B 
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activity displayed by LiaS towards WT-LiaR. Moreover, the rate of dephosphorylation from the 
phosphotransfer experiments was determined to be 0.1042 ± 0.0060 s-1 Figure 2.1.12. Because of 
its ability to phosphorylate and dephosphorylate substrates, LiaS, has a bifunctional role in signal 
transduction. The relevance of Asp54 as the predicted site of phosphorylation on LiaR was 
investigated by performing a phosphotransfer reaction between LiaS and LiaR D54A. As 
illustrated in Figure 2.1.13, and as expected, LiaS, was able to successfully phosphorylate WT-
LiaR. |On the other hand, mutant form LiaR D54A, demonstrated little if any phosphorylation by 
LiaS. It is thus evident that the two versions of LiaR are distinctly different as far as their ability 
to receive a phosphate from LiaS. 
The receiver domain of LiaR (LiaRN) was also able to get phosphorylated by LiaS, albeit to a lesser 
extend than WT-LiaR. Interestingly, the rate of phosphorylation of LiaRN was much slower than 
that of full-length LiaR. As seen in Figure 2.1.14, only about 30% of the phosphate on LiaS was 
transferred to the N terminal domain of LiaR, with a calculated phosphorylation rate of 0.0828 ± 
0.0325 s-1. Additionally, LiaS does not display any phosphatase activity towards LiaRN, as 
indicated by a negative rate of dephosphorylation (Figure 2.1.15). These observations with respect 
to the low phosphorylation and lack of phosphatase activity suggested the role of the C-terminal 
for complete phosphorylation as well as for a physical interaction between LiaS and the C-terminal 
to aid in dephosphorylation of LiaR.  
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Figure 2.1.11 In vitro Phosphotransfer between GST-LiaS and LiaR using radioactive ATP 
at room temperature 
A: 5 µM of [γ - 32P]-ATP phosphorylated LiaS was used as the control. Phosphorylated GST- 
LiaS was added to LiaR samples in a concentration ratio of 1:5. The samples were quenched with 
5X SDS dye at time intervals ranging from 0.5 min to 8 min for the phosphotransfer to occur and 
was analysed using 15% SDS-PAGE. The gel was exposed to a phosphoscreen for 2 h and scanned 
with a Typhoon scanner. B: Phosphorylated GST- LiaS mixed with LiaR at room temperature. 
15% SDS-PAGE gel stained with Coomassie Blue demonstrating loading concentrations C: 
Quantified data using the ImageJ software showing the rate of phosphotransfer. 
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Figure 2.1.12 Band intensity of phosphorylated LiaR, via phosphotransfer reactions between 
GST-LiaS and LiaR using radioactive ATP.  
Quantified using ImageJ and plotted against time. The data were fitted using GraFit software to 
pseudo first order equation to calculate rate constant. 
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Figure 2.1.13 In vitro Phosphotransfer between GST-LiaS and WT-LiaR and LiaR D54A 
using radioactive ATP at room temperature 
A: 5 µM of phosphorylated GST- LiaS was added to WT-LiaR and LiaR D54A samples in a 
concentration ratio of 1:5. The samples were quenched with 5X SDS dye at time intervals ranging 
from 0.5 min to 5 min. Samples were analyzed using gel electrophoresis (15% SDS-PAGE gel). 
The exposed gel shows that mutation of the aspartate residue at position 54 renders the protein 
incapable of receiving a phosphate group from its cognate histidine kinase, LiaS. B: 
Phosphorylated GST- LiaS mixed with WT and mutant LiaR at room temperature. 15% SDS-
PAGE gel, stained with Coomassie Blue, demonstrating loading concentrations. 
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Figure 2.1.14 In vitro Phosphotransfer between GST-LiaS and LiaRN using radioactive ATP 
at room temperature 
A: 5 µM of phosphorylated GST-LiaS serving as the control was added to WT-LiaR and LiaRN 
samples in a concentration ratio of 1:5. The samples were quenched with 5X SDS dye at time 
intervals ranging from 0.5 min to 5 min for the phosphotransfer to occur and were analysed using 
a 20% SDS-PAGE gel. The gel was exposed to a phosphoscreen for 2 hr and scanned with a 
Typhoon scanner. B: Image of the 20% SDS-PAGE gel, stained with Coomassie Blue, displaying 
loading concentrations. C: Quantified data using the ImageJ software displaying a slower rate of 
phosphotransfer for LiaRN compared to WT-LiaR. 
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Figure 2.1.15 Band intensity of phosphorylated LiaR, via phosphotransfer reactions between 
GST-LiaS and LiaRN using radioactive ATP. Quantified using ImageJ and plotted against 
time. The data were fitted using GraFit software to pseudo first order equation to calculate 
rate constant. 
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3.5 Determination of effect of phosphorylation of LiaR and its variants upon by a 
small phosphor-donor.  
Homologous RR from other species when subjected to phosphorylation with acetyl phosphate are 
said to undergo a change from monomeric to a dimeric species. LiaR and its variants were all 
examined using various techniques such as Native PAGE, Phos-tag TM gel, Mass spectrometry and 
Analytical ultracentrifugation for LiaRN in particular to help with studying the importance of the 
C-terminal for phosphorylation and also the conformational implications.  
3.5.1  Oligomeric structure changes of LiaR and its variants following 
phosphorylation as revealed by Native-PAGE 
Addition of 50 mM lithium potassium acetyl phosphate (37 °C for 1 hr) to LiaR resulted in 
phosphorylation.  
The use of Native-PAGE ensured that the protein would not denature as the gels lack SDS.  
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                                             WT-LiaR                                   VraR  
Conc (µM)                   20       20       20       40        40      40      20       20      20 
AcPO4(50mM)            -          +         +         -         +        +        -          +        +       
LiaS (10µM)                -           -         +         -          -        +         -          -        +        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1.16 Oligomerization of WT-LiaR, showing the native monomeric and dimeric 
states and an equilibrium shift upon phosphorylation with the small phospho-donor, acetyl 
phosphate 
A: A 10% Native-PAGE gel used to analyse the oligomeric properties of LiaR with VraR serving 
as a positive control. Samples were phosphorylated by acetyl phosphate (37 °C for 1 hr) and 10 
µM WT- LiaS was subsequently added to phosphorylated samples and incubated for an additional 
10 min to investigate its phosphatase activity. B: A 10% Native - PAGE gel was used for the 
analysis of the oligomeric properties of LiaR in its native and phosphorylated state. 10 µM 
LiaSH159A was added to phosphorylated samples and incubated for an additional 10 min in order 
to detect its phosphatase activity.  
A 
                                                 WT-LiaR 
Conc (µM)                     20         20       20       40        40        40    
AcPO4(50mM)               -           +         +          -           +         +      
LiaSH159A(10µM)        -            -          +         -            -         +        
B 
Dimeric species 
Monomeric species 
Dimeric species 
Monomeric species 
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The results obtained from Native-PAGE indicated that WT-LiaR exists primarily as a monomeric 
and dimeric mixture. Following phosphorylation of LiaR, a shift in the equilibrium between the 
dimeric and monomeric state was observed with the monomeric state being the predominant form 
(quantified using Image J software version 1.4s) (Figure 2.1.16).  
In order to gain additional insight into the structural determinants responsible for the assembly of 
the dimerization interface, 3 distinct mutants of WT-LiaR were constructed (LiaR T198A, LiaR 
V202A and LiaR H205A). These mutants behave similarly to WT-LiaR in their native state as 
they appear to exist as a mixture of monomeric and dimeric species. Following phosphorylation, 
there appears to be a slight shift in equilibrium between monomeric and dimeric species although 
this is not clearly visible in the native gels shown in Figure 2.1.17 A-C. This is further 
corroborated by changes observed in the CD spectra following phosphorylation Table 1.  Finally, 
as seen in Figure 2.1.17 D the oligomeric state of LiaRN does not change pre or post 
phosphorylation with the latter existing as a monomeric and dimeric mixture. These results are 
helped us understand that the dimerization interface was not present on Threonine (198), Valine 
(202) or Histidine (205). Additionally, the results obtained for N terminals oligomeric state were 
particularly intriguing, which were followed up with further studies like Mass spectrometry and 
Analytical ultracentrifugation.  
 
 
 
 
 
 58 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1.17 Oligomerization states of LiaR variants, showing pre and post phosphorylation 
dimeric and monomeric states {A- C Data shown from Le, 2017 and used with permission} 
A, B, C: 10% Native - PAGE gel was used to analyse the oligomeric properties of LiaR T198A, 
LiaR V202A and LiaR H205A pre and post phosphorylation D:15% Native - PAGE gel was used 
to analyse the oligomeric properties of LiaRN with or without the addition of acetyl phosphate. 
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3.5.2 Analysis of phosphorylation WT-LiaR, LiaRN, LiaR D54A by acetyl phosphate 
using Phos-tag TM analysis 
Phos-tag SDS-PAGE is used for the separation and detection of large phosphoproteins. In brief, 
the gel separates phosphorylated species from non-phosphorylated species based on the principle 
that the phosphorylated species migrate slower due to charge interactions between the negatively 
charged PO4- and the positively charged Mn2+ ions chelated on the Phos-tag chemical (Kinoshita, 
et al;, 2006). In this series of experiments, Phos-tag TM analysis was used to describe the rate of 
phosphorylation of WT-LiaR, LiaR D54A and LiaRN (Figures 2.1.18 and 2.1.19). More than half 
(53%) of WT-LiaR is phosphorylated within an hour of incubation with acetyl phosphate and the 
rate constant for the reaction was calculated to be 0.0325 ± 0.0055 s-1 (Figures 2.1.20). As 
expected LiaR D54A was not subject to phosphorylation, indicating a key role for the aspartate 
residue in the phosphate transfer. Lastly, the rate of phosphorylation of LiaRN was significantly 
slower when compared to WT-LiaR with the extent of phosphorylation remaining constant from 
5 min to 60 min unlike the full-length protein where there is a steady increase seen. 
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Figure 2.1.18 Phos-tag TM gel analysis of WT-LiaR and LiaR D54A  
A: A 12.5% SDS-PAGE gel was used to analyse WT-LiaR and LiaR D54A samples 
phosphorylated using acetyl phosphate. Lane C shows the control LiaR samples prior to the 
addition of acetyl phosphate, while 15, 30, 45 and 60 min display a steady increase in the rate of 
phosphorylation over time. WT-LiaS and LiaS H159A were used for dephosphorylation WT-LiaR. 
B: Graph displaying quantification of the data obtained using for Phos-tag TM gel analysis for WT-
LiaR. 
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Figure 2.1.19 Phos-tag analysis of LiaRN  
A: An 18% SDS-PAGE gel was used to analyze phosphorylation of LiaRN. Lane C shows control 
LiaR samples without acetyl phosphate. B: Graph quantifying phosphorylation data for LiaRN.  
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Figure 2.1.20 Band intensity of LiaR and LiaRN phosphorylated by acetyl phosphate were 
quantified using ImageJ and plotted against time. The data were fitted using GraFit software 
to pseudo first order equation to calculate rate constant. 
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3.5.3 Mass spectrometry analysis for LiaRN 
Mass spectrometry (MS) allows us to study signaling by allowing rapid identification of 
phosphorylation sites with precision and sensitivity. Upon phosphorylation, a protein shows an 
additional mass of 80 Da corresponding to the phosphate group PO4- (Noah Dephourea, 2013). In 
order to confirm the ability of LiaRN to be phosphorylated, we used mass spectrometry. As seen 
in Figure 2.1.21 no change in the spectrum was observed following the addition of acetyl 
phosphate as the molecular weight of the protein remained unchanged (~14028 Da) pre and post 
the addition of acetyl phosphate. This result was unexpected as the primary role of the receiver 
domain is to be phosphorylated on the aspartate reside. Two possible justifications can be given 
for the same, one being incorrect sample preparations, i.e. the centrifugation was breaking the 
phosphate bond and hence was not detected by the machine. The second reason being a detection 
limit which makes the low rate of phosphorylation difficult to be caught by the machine. Thus 
showing negative results. 
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Figure 2.1.21 Mass Spectrometry studies for LiaRN for assessment of phosphorylation 
LiaRN was phosphorylated using acetyl phosphate and then subjected to mass spectrometry for 
molecular weight assessment. There were no quantifiable changes in the weight for 
unphosphorylated A and phosphorylated B sample seen in the spectra. Here m stands for mass and 
m/z signifies the mass to charge ratio. 
 
3.5.4 Analytical ultracentrifugation studies for LiaRN 
Analytical ultracentrifugation (AUC) permits real-time observation of sedimentation behavior of 
proteins. Information from the shape of the sedimentation profiles permits the identification and 
determination of the equilibrium between different oligomeric states. AUC sedimentation studies 
were conducted in the Department of Biochemistry at the University of Toronto.  
AUC experiments for 0.25 mg/ml, 0.50 mg/ml and 1 mg/ml of LiaRN indicated that LiaRN the 
monomer-dimer model was fit for LiaRN. 1.1:1 was the ratio attained after fixing the molecular 
A B 
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weight (MW) to the theoretical MW of the monomer, and the deduced association constant Ka was 
0.074 µM (Figure 2.1.22). 
 
 
 
Figure 2.1.22 Analytical ultracentrifugation run of LiaRN samples 
Fitting of the absorbance values at 280 nm against radius of the protein (bottom panel) and the plot 
of the residuals (top panel). Experimental data were obtained at 0.25 mg/ml, 0.5 mg/ml and 1 
mg/ml LiaRN sample. The obtained data was found to be fit for a monomer-dimer model. 
 
 
3.6 DNA binding ability of WT-LiaR and its variants 
3.6.1  Electrophoretic Mobility shift assay (EMSA) 
In order to study the DNA-binding properties of LiaR and its variants, the end-labeled PliaSR DNA 
fragment was incubated with increasing concentrations of LiaR and its variants. The promoter 
sequence was determined by studying the primer extension analysis and the full-length sequence 
provided by Jordan Sina, et al; 2006. The resulting DNA-protein complexes were separated from 
free DNA on 9% non-denaturing polyacrylamide gels. EMSA experiments conducted using WT-
LiaR demonstrated a high binding affinity towards the promoter region of liaSR. In addition, 
Model Monomer-Dimer 
Ka 0.074  
Variance 6.47 
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phosphorylation of WT-LiaR had very little impact on its ability to bind to the DNA. The KD 
values for phosphorylated and unphosphorylated WT-LiaR samples were 0.3006 ± 0.005 µM and 
0.337 ± 0.027 µM respectively (Figure 2.1.23). LiaR D54A was also able to bind to the promoter 
region of liaSR as demonstrated by the KD values (0.355 ± 0.4242 µM and 0.333 ± 009) pre and 
post phosphorylation (Figure 2.1.24).  
Similar studies were also conducted for the full-length LiaR mutants (LiaR T198A, LiaR V202A 
and LiaR H205A). All mutants exhibited binding patterns similar to the WT protein under both 
phosphorylated and unphosphorylated conditions suggesting that the mutations had no effect on 
the DNA binding ability of the response regulator (Figure 2.1.25 and 2.1.26). This is also apparent 
by the KD values calculated for the mutants pre and post phosphorylation (Table 1). These values 
are also very similar to the ones obtained for the WT protein. This suggested that the mutations 
had no effect on the proteins ability to bind to the DNA. 
Finally, EMSA demonstrated that the effector domain of LiaR (LiaRC) is unable to bind to the 
promoter region of liaSR. Increasing the protein concentration or phosphorylating the protein did 
not modify its ability to bind to the DNA as seen in Figure 2.1.27. 
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Figure 2.1.23 DNA binding affinity of WT-LiaR for the liaSR promoter 
A: DNA binding affinity of WT-LiaR to the liaSR promoter under unphosphorylated conditions. 
B: DNA binding affinity of WT-LiaR-P the liaSR promoter post phosphorylation.  C:  Percentage 
of bound DNA plotted against protein concentration for both the experimental conditions.  
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Figure 2.1.24 DNA binding affinity of LiaR D54A on the liaSR promoter 
A: DNA binding ability of LiaRD54A to the liaSR promoter under unphosphorylated conditions. 
B: DNA binding ability of LiaRD54A incubated with acetyl phosphate.  
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Figure 2.1.25 DNA binding affinity of LiaR mutants (T198A, V202A and H205A) for the 
liaSR promoter 
A: DNA binding affinity of LiaR T198A, LiaR V202A and LiaR H205A to the liaSR promoter 
under unphosphorylated conditions. B: DNA binding ability of LiaR T198A, LiaR V202A and 
LiaR H205A to the liaSR promoter following phosphorylation.  
A B 
              Unphosphorylated LiaR T198A 
Conc(µM) 0   0.1 0.2 0.4 0.60.8   1    4   5   10  
              Phosphorylated LiaR T198A 
Conc(µM) 0   0.1 0.2 0.4 0.60.8   1    4   5   10  
              Unphosphorylated LiaR V202A 
    Conc(µM) 0   0.1 0.2 0.4 0.6 0.8   1   4   5  10  
              Phosphorylated LiaR V202A 
  Conc(µM) 0   0.1 0.2 0.4 0.60.8  1    4   5   10  
              Unphosphorylated LiaR H205A 
  Conc(µM) 0   0.1 0.2 0.4 0.60.8  1   4    5   10  
              Unphosphorylated LiaR H205A 
  Conc(µM) 0 0.1 0.2 0.4 0.60.8  1    4    5   10  
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Figure 2.1.26 EMSA quantification of the binding affinity of LiaR mutants towards the liaSR 
promoter 
The affinity of LiaR mutants (LiaR D54A, LiaR T198A, LiaR V202A and LiaR H205A) towards 
the promoter. The percentage of bound DNA pre and post phosphorylation was plotted against the 
protein concentration. 
 
Table 2: KD values determined for WT-LiaR and its variants  
Protein Unphosphorylated Phosphorylated 
WT-LiaR 0.3006 ± 0.0050 0.3370 ± 0.7220 
LiaR D54A 0.3550 ± 0.4242  0.3330 ± 0090 
LiaR T198A 0.3669 ± 0.456 0.3733 ± 0.2781 
LiaR V202A 0.4001 ± 0.9121 0.3788 ± 0.576 
LiaR H205A 0.4220 ± 0.1000 0.4169 ± 0.016 
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Figure 2.1.27 DNA binding of LiaRC to the liaSR promoter 
A: Unphosphorylated LiaRC B: Phosphorylated LiaRC. LiaRC is unable to bind to the promoter of 
liaSR pre or post phosphorylation at varying concentrations. 
 
3.6.2 DNase-I footprinting analysis 
Having established that LiaR is able to bind to the promoter of liaSR, the next step was to map in 
detail the exact nucleotide sequence of the binding site using DNase I footprinting assay. WT-
LiaR, LiaRD54A and LiaRC were used for the assays displayed in Figure 2.1.28 and 2.1.29. 
Interestingly, in the presence of unphosphorylated WT and LiaR D54A one common region of 
protection is evident (designated as R1). Remarkably, in addition to the first area of protection 
(consensus), upon phosphorylation a secondary region of protection is readily observed for WT-
LiaR (designated as R2). The absence of the secondary protection site in the mutant protein is 
indicative of the importance of phosphorylation in inducing structural changes in the protein thus 
altering DNA binding. As far as LiaRC is concerned, and as expected, there was no protection 
observed from DNase I cleavage. The primary site of protection was also lacking, additionally 
representing the importance of the N-terminus in the instrumental role of LiaR for DNA binding 
(Figure 2.1.29). 
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Figure 2.1.28 WT-LiaR and LiaR D54A DNase-I footprinting on the labelled top strand of 
the liaSR promoter 
Lanes 1, 5, 9, 10, and 16 represent the controls having no protein. Lanes 2-4 represent different 
protein concentrations of unphosphorylated WT-LiaR. Lanes 6-8 represent phosphorylated WT-
LiaR. Lanes 11-12 represent unphosphorylated LiaR D54A samples in concentrations 5 and 10 
µM. Lanes 14-15 represent phosphorylated LiaRD54A. The secondary binding site appears when 
WT-LiaR is phosphorylated, demonstrating extra protection from DNase I cleavage.  
 
R2 
R1 
                                     WT LiaR                          LiaR D54A 
Conc (µM)        C   2   5  10 C  2   5  10  C  C   5  10 C   5  10  C 
AcPO4              *    -    -    -  *   +   +  +   *   *    -    -   *   +   +   * 
+31 
-161 
 73 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1.29 LiaRC DNase-I footprinting on labelled top strand of the liaSR promoter 
Lanes 1, 7, 8 and 13 represent the controls having no protein. Lanes 2-6 represent different 
concentrations of unphosphorylated LiaRC. Lanes 9-12 represent varying concentrations of 
phosphorylated LiaRC.  
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3.7 Investigation of cross-communication between the LiaSR and VraSR TCSs 
LiaSR from B. subtilis and VraSR TCS from S. aureus share a high sequence similarity. 
Considering the high sequence resemblance, one can not help but wonder if the two distinct TCSs 
are capable of cross talk. In order to address this possibility additional phosphotransfer as well as 
DNase I footprinting experiments were conducted.  
As seen in Figure 2.1.30, autophosphorylated GST-VraS (P32) was able to transfer its phosphoryl 
groups onto LiaR, when the two proteins were co-incubated. LiaR was able to extract 90% of the 
phosphoryl groups from GST-VraS within a span of less than 30 seconds. In addition, the observed 
drop in the phosphorylation signal from 2-12 min is indicative of the phosphatase activity that 
VraS is exhibiting towards its non-cognate response regulator LiaR. The estimated pseudo first 
order rate constant for the phosphotransfer reaction was calculated to be 3.2129 ± 0.7339 s-1, while 
the rate of dephosphorylation was established to be 0.3604 ± 0.0336 s-1 by using GraFit software.  
On the contrary, when autophosphorylated LiaS was co-incubated with VraR, phosphotransfer was 
still occurred albeit to a much weaker extent. Only 25% of the phosphoryl groups successfully 
transferred from LiaS to VraR in the first 30 sec all the way up to 5 min (Figure 2.1.31). 
Furthermore, LiaS did not exhibit any phosphatase activity towards VraR an observation that is 
further corroborated by previous Native-PAGE experiments (Figure 2.1.16 A).  
Lastly, in order to investigate the ability of LiaR to bind to the promoter of VraSR, DNase I 
footprinting experiments were conducted. Accordingly, when the PvraSR locus was exposed to 
DNase I cleavage, LiaR and VraR both demonstrated protection. However, the protection 
intensities were different for both the proteins (Figure 2.1.32). These results cumulatively help us 
show how the two component systems can cross talk using signal transduction. Possibly how a 
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non pathogenic bacterium can learn how to combat antibiotics and gain resistance from a resistant 
strain. Through this study we can predict that in vivo VraS from S. aureus can signal LiaR from B. 
subtilis, eventually causing gene expression to aid in cell wall synthesis and perhaps even 
resistance from antibiotics. Further the DNase 1 footprinting assay also corroborates that LiaR can 
bind to the vraSR gene promoter to carry out further downstream actions in S. aureus. 
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Figure 2.1.30 : In vitro Phosphotransfer between GST-VraS and LiaR using radioactive ATP 
at room temperature 
A: 5 µM of [γ - 32P]-ATP phosphorylated VraS was used as the control. Phosphorylated GST- 
VraS was added to LiaR samples in a concentration ratio of 1:5. The samples were quenched with 
5X SDS dye at time intervals ranging from 0.5 min to 12 min for the phosphotransfer to occur and 
was analysed using 15% SDS-PAGE. The gel was exposed to a phosphoscreen for 2 hr and 
scanned with a Typhoon scanner. B: Phosphorylated GST- VraS mixed with LiaR at room 
temperature. 15% SDS-PAGE gel stained with Coomassie Blue demonstrating loading 
concentrations C: Quantified data using the ImageJ software showing the rate of phosphotransfer. 
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Figure 2.1.31  In vitro Phosphotransfer between GST-LiaS and VraR using radioactive ATP 
at room temperature 
A: 5 µM of [γ - 32P]-ATP phosphorylated LiaS was used as the control. Phosphorylated GST- 
LiaS was added to VraR samples in a concentration ratio of 1:5. The samples were quenched with 
5X SDS dye at time intervals ranging from 0.5 min to 5 min for the phosphotransfer to occur and 
was analysed using 15% SDS-PAGE. The gel was exposed to a phosphoscreen for 2 hr and 
scanned with a Typhoon scanner. B: Phosphorylated GST- LiaS mixed with VraR at room 
temperature. 15% SDS-PAGE gel stained with Coomassie Blue demonstrating loading 
concentrations C: Quantified data using the ImageJ software showing the rate of phosphotransfer. 
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Figure 2.1.32 WT-LiaR and VraR WT terminal domain DNase-I footprinting on the labelled 
top strand of the vraSR promoter 
Lanes 1 and 8 represent the controls having no protein. Lanes 2-7 represent different 
concentrations of unphosphorylated and phosphorylated VraR WT. Lanes 9-13 represent 
phosphorylated and unphosphorylated WT-LiaR 
 
R2 
R1 
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3.7.1 Investigation of protein-protein interactions by pull-down assays of GST-LiaS 
and LiaR, GST-LiaS and VraR, GST-VraS and LiaR and His-VraS and GST-LiaS 
Analysis of heterodimer structures can provide insight into the principles of protein-protein 
complex formation and help develop models to predict interaction sites. In order to investigate the 
physical interaction between the HK and its cognate RR, resin-bound GST-LiaS was incubated 
with LiaR. LiaR displayed no physical interaction with LiaS despite the phosphor signal transfer 
between the two (Figure 2.1.33 A). When GST-VraS was incubated with LiaR, no co-elution was 
observed (Figure 2.1.33 B) in antithesis to the results obtained from the phosphotransfer reactions. 
Similarly, no protein-protein interaction was observed between GST-LiaS and VraR as seen in 
Figure 2.1.33 C.   
Since the gene sequences of VraS and LiaS share a 53% sequence identity, we sought to investigate 
whether these two proteins interacted to form a heterodimer. His-VraS was immobilized on Ni-
NTA resin and was co-incubated with its homolog GST-LiaS. As seen in Figure 2.1.33 D, the two 
proteins appear to co-elute together and thus interact. However, independent experiments using 
GST-tagged LiaS indicated that the GST tag can non-specifically bind to the Nickel column. 
Collectively these results demonstrate that a true interaction between the two proteins is unlikely. 
In conclusion, all the protein combinations did not demonstrate any binding with respect to 
heterodimer formation implying weak or no physical interactions. 
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Figure 2.1.33 Pull down assays to study protein-protein interaction 
A: GST-LiaS was immobilized onto glutathione resin and LiaR was co-incubated. Unbound 
proteins were washed and then eluted (E1-E5) with 10 mM reduced glutathione in 50 mM Tris 
(pH 8.0) buffer. B: GST-VraS was immobilized onto glutathione resin and LiaR was co-incubated. 
Unbound proteins were washed and then eluted (E1-E5) with 10 mM reduced glutathione in 50 
mM Tris (pH 8.0) buffer.  C: GST-LiaS was immobilized onto glutathione resin and VraR was co-
incubated. Unbound proteins were washed and then eluted (E1-E5) with 10 mM reduced 
glutathione in 50 mM Tris (pH 8.0) buffer. D: His-VraS was immobilized onto Ni-NTA resin and 
was co-incubated with its homolog GST-LiaS. Unbound proteins were washed and then eluted 
(E1-E4) with 250 mM Sodium phosphate buffer (pH 8.0). 
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4 Discussion and Conclusions 
The development of counter strategies to stress and resistance mechanisms, represent common 
survival strategies adopted by soil bacteria in an attempt to survive a hostile and unforgiving 
habitat (D'Costa et al., 2006). During infection, bacterial gene expression is modulated by multiple 
regulatory elements such as DNA-binding proteins, regulatory RNAs, sigma factors and TCSs 
(Kolar et al., 2011). The TCS is the primary modulator of gene expression in response to external 
stimuli. As the name suggests, TCSs are composed of two elements: a membrane-associated 
histidine kinase and a response regulator located within the cytoplasm. TCSs essentially counteract 
stress by detecting changes in the external environment and accordingly reprograming gene 
expression. B. subtilis, possesses four key TCSs involved in maintenance of cellular wall integrity 
(Jordan Sina, 2006). The LiaSR TCS responds to a relatively broad range of stimuli, in comparison 
to other TCSs which are very specific to drug sensing and detoxification only (Rietkötter et al., 
2008).    
Most of our current knowledge of the LiaSR TCS in B. subtilis (strain 168) is the product of 
research of homologs from other bacteria or the result of in vivo studies. My studies are unique 
because for the first time they attempt to investigate in detail the molecular mechanisms of signal 
transduction of the LiaSR TCS in vitro in B. subtilis. 
LiaS’ cytosolic portion (excluding the transmembrane domain) was successfully cloned, expressed 
and purified as previously described (Belcheva & Golemi-Kotra, 2008). The truncated version of 
LiaS (GST-LiaS), which only possessed the DHp and the CA domains was able to 
autophosphorylate in the presence of radiolabelled ATP. This finding is in accordance with 
previously published studies on IM-HK (Mascher, 2006).  The affinity of LiaS towards ATP was 
very high as demonstrated by a Km value of ~ 3 µM, indicating that only a small concentration of 
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ATP is required for achieving 50% maximal phosphorylation. Because the intracellular levels of 
ATP are in the millimolar concentration, phosphorylation of LiaS in the cell is highly likely as a 
response to any stress related stimuli. 
Depending on the nature of the environmental stimulus, HKs can either autophosphorylate and 
serve as phosphor-donors for the RR or promote their rapid dephosphorylation (Kenney, 2011). 
Similarly, in vivo studies have demonstrated that LiaS (a member of the HisKA_3 subfamily) is a 
bifunctional HK that also acts as a phosphatase on LiaR in the absence of a stress stimulus (Karen 
Schrecke, 2013). Like other known TCSs, LiaS can transfer its phosphate group to LiaR in vitro 
with 50% of the transfer occurring within the first 30 secs (rate constant = 0.0609 ± 0.0288 s-1) 
(Figure 2.1.12 & 2.1.13). This rapid phosphotransfer suggests that in the presence of cell wall 
stress this system is readily activated resulting in high levels of phosphorylated LiaR 
intracellularly.  It was also demonstrated that phosphorylation levels of LiaR were tightly regulated 
by the phosphatase activity of LiaS as evident by phosphotransfer experiments and PhostagTM 
analysis (Figure 2.1.19). The results obtained here, are particularly interesting in light of a recent 
in vitro study of the LiaSR TCS of S. mutans demonstrating that phosphorylated LiaR is relatively 
stable for up to 30 min as LiaS does not dephosphorylate LiaR (Manoharan Shankar, 2015).  
In order to confirm the identity of the site of autophosphorylation on LiaS, mutation of histidine 
(residue 159) to alanine (LiaS H159A) was carried out based on available sequence information 
on Uniprot [(UniProtKB - O32198 (LIAS_BACSU)]. Mutation of the phosphohistidine severely 
curtailed autophosphorylation as demonstrated by the phosphor screen experiments. However, the 
phosphatase activity of LiaS H159A towards LiaR was unaltered as demonstrated by Native-
PAGE and PhostagTM experiments. Phosphatase activity in the HisKA_3 subfamily of HKs is 
typically controlled by a conserved glutamine (residue 164 and a conserved DxxxQ motif recently 
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identified in DesK and NarX/Q (Albanesi et al., 2004; Schroder et al., 1994). Perhaps mutating 
glutamine 164 in the LiaS sequence would lead to an impairment in its phosphatase activity. The 
lack of phosphatase activity for LiaSH159A could also be attributed to the fact that in our in vitro 
model LiaF was absent. In vivo, LiaF acts as an inhibitor of the LiaSR signal transfer forming the 
stimulus perception complex (Karen Schrecke, 2013).   
Phosphorylation of the aspartic acid residue on the RR is the hallmark of TCSs that orchestrates 
the adaptive responses of bacteria in response to their surroundings. The aspartylphosphate residue 
on the N-terminal of LiaR was mutated to alanine based on the Uniprot predicted site [(UniProtKB 
- O32197 (LIAR_BACSU)].  The mutation was tested to see if LiaR D54A could indeed accept 
phosphate groups from LiaS via phosphotransfer reactions at various time intervals. As 
demonstrated in Figure 2.1.14, while WT-LiaR readily accepted the phosphate transferred by 
LiaS, the D54A mutant, appeared largely unable to get phosphorylated. However, there appears to 
be a very faint band on the phosphotransfer gel portrayed in Figure 2.1.14. This very faint band 
could potentially be attributed to GST contamination, since LiaR and GST have almost identical 
molecular weights (23.125 KDa and 26 KDa respectively) and additionally GST protein gets 
phosphorylated. In addition, it is also possible that the signal diminishes after 5 min due to auto-
dephosphorylation of LiaS when incubated with a |RR, not necessary that the RR picks up the 
signal. That is LiaS loses its signal but is not accepted by the response regulator, in this case 
because the mutant LiaR D54A lacks an aspartate group.   
Acetyl phosphate is a small molecule phospho-donor capable of phosphorylating RRs in vivo, 
since it can reach intracellular concentrations comparable to those of ATP (McClearly et al., 1993). 
As can be demonstrated in Figure 2.1.19, WT-LiaR readily became phosphorylated as indicated 
by the retarded migration of phosphorylated LiaR during protein electrophoresis in the presence 
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of PhosTagTM. Based on the aforementioned results, the rate of phosphorylation for LiaR was 
determined. It is worth mentioning that maximal phosphorylation occurs over a period of 1 hr 
where it tends to saturate. On the other hand, LiaRD54A remained unphosphorylated as revealed 
by the absence of a shift in electrophoretic mobility, indicating that phosphorylation by acetyl 
phosphate is unlikely.  
The modular architecture of RRs comprises a conserved receiver domain and a variable effector 
domain which allow RRs to function as phosphorylation-regulated switches that manage a wide 
variety of cues (Barbieri et al., 2010).  Studies on various RRs such as S. aureus VraR and the 
more widely characterized OmpR/PhoB winged-HTH transcription factor subfamilies have 
demonstrated a phosphorylation-dependent oligomerization assembly from monomers to dimers, 
responsible for the recognition of specific DNA target sites (Belcheva & Golemi-Kotra, 2008). 
The phosphorylation-dependent oligomerization and structure of LiaR from E. faecium has been 
studied using Beryllium Trifluoride (BeF3 -), a noncovalent mimic of a phosphoryl group aiding 
in the formation of a stable analog of the phosphorylated protein. In the same article the authors 
used analytical ultracentrifugation, and demonstrated that unphosphorylated E. faecium LiaR 
existed nearly exclusively as a monomer in solution with a dissociation constant of 1600 μM and 
that addition of BeF3 - promoted dimer formation (Kd = 15 μM) (Davlieva et al., 2016).  
Upon phosphorylation with acetyl phosphate, S. aureus VraR displays a change in its oligomeric 
state as revealed by a shift in its spectrum using CD (Belcheva & Golemi-Kotra, 2008). Similarly, 
B. subtilis WT-LiaR also displayed a change in its spectrum prompting us, to further analyze its 
oligomeric state by using Native-PAGE. Surprisingly, these experiments indicated that LiaR 
existed as a mixture of monomers and dimers in its unphosphorylated state.  Upon 
phosphorylation, a transition was observed between the monomeric and dimeric species present. 
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Because of this shift in equilibrium the apparent dissociation constant could not be calculated and 
thus no comparisons could be drawn regarding the rate of phosphorylation of LiaR by LiaS and 
acetyl phosphate.  
Further we attempted to decipher the amino acids involved in maintaining the dimer interface of 
LiaR in B. subtilis. A recent study (Davlieva et al., 2015) on LiaR from E. faecalis (S613), showed 
a dimer-tetramer equilibrium model. Using Swiss PDB viewer we analysed the structure of the 
DNA-binding domain of LiaR from E. faecalis (Figure 1.1.5) to draw reference for our protein of 
interest. The C-terminus of LiaR from B. subtilis was subjected to sequence alignment with LiaR 
from E. faecalis. Three conserved amino acids at the dimerization interface, namely, threonine, 
isoleucine, and phenylalanine at positions 198, 202 and 205 respectively (refer to figure in the 
APPENDIX D) were identified. The relevant mutations on full-length LiaR and LiaRC were 
carried out with the presumption that loss of any one of the three residues would result in the loss 
of the ability of the protein to dimerize. However, mutants of LiaRC (LiaRC T198A, LiaRC V202A 
and LiaRC H205A) could not be efficiently purified and thereby characterized therefore the same 
mutations in the full-length LiaR protein. The resulting mutants (LiaR T198A, LiaR V202A and 
LiaR H205A) folded similarly to the WT protein as confirmed by their respective CD spectrums, 
as well as Native-PAGE and EMSA profiles. This in turn implies that perhaps the dimerization 
interface is rather located on the N-terminus of the protein. 
LiaR from B. subtilis has been classified as a transcription factor, based on its ability to recognize 
and bind the promoter sequence (Mascher et al., 2004). My studies addressed the DNA binding 
ability of LiaR to the aforementioned liaSR promoter. Moreover, the transcriptional start site was 
mapped upstream of liaI using primer extension analysis. In the 60 nucleotides between the -35 
region and the putative terminator of yvqJ, a 6-nucleotide direct repeat (TCCGGT) with a 12-
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nucleotide spacing was identified as a candidate site for DNA binding by LiaR (Mascher, et al., 
2004). In contrast to this study that demonstrated that phosphorylation was a prerequisite for DNA 
binding to the promoter, WT-LiaR in my experiments displayed a strong binding affinity towards 
the liaSR promoter pre and post-phosphorylation (Mascher et al., 2004). The KD values obtained 
were lower than these described for homologous proteins like VraR (5 ± 2 µM) as well as LiaR 
(4.13 ± 0.48 μM), signifying a higher affinity for the promoter (Davlieva et al., 2015; Belcheva & 
Golemi-Kotra, 2008). Interestingly, the mutant LiaR D54A showed KD values similar to that of 
the WT protein reiterating the fact that phosphorylation made little or no impact on the ability of 
LiaR to bind to the DNA. When the 192 bp liaSR promoter sequence was labeled and subjected to 
DNase I cleavage, a novel binding site was observed (designated as R1). In addition, upon 
phosphorylation of LiaR, a secondary binding site on the promoter is apparent (designated as R2) 
suggesting that LiaR either undergoes a conformational change (i.e. tetramer formation) or recruits 
more dimers to the vicinity of the promoter. Unfortunately, the exact base sequence of the 
protection area could not be determined as the sequencing standards were not working in the lab. 
However, the data supports previously published work with respect to LiaR binding site and 
sequence identity (Wolf et al., 2010). Furthermore, DNase I hypersensitive sites were observed 
above and below the R2 protected sequence where protection and reactivity increased. In turn, it 
is possible that WT-LiaR binding to the promoter induces structural alterations or changes in the 
curvature of the DNA thereby facilitating DNase I cleavage. Studies with other homologous 
response regulators (i.e. LiaR from E. faecalis) have also demonstrated similar findings with 
respect to hypersensitivity sites and thereby the probable bending of DNA (Davlieva et al., 2015). 
The DNA binding results on LiaR from B. subtilis obtained here are comparable to previously 
published data on LiaR from E. faecium and E. faecalis and its homolog VraR from S. aureus 
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(Belcheva & Golemi-Kotra, 2008; Davlieva et al., 2015; Davlieva et al., 2016). However, these 
findings with respect to the binding affinity and protection sites for LiaR from B. subtilis can be 
considered novel. 
In order to gain insight into the structure and function of LiaR, its conserved receiver and effector 
domains were cloned independently. Site-directed mutagenesis to mutate Gly131 on the full-length 
gene was used to introduce a stop codon, creating LiaRN. The purification was carried out by 
DEAE and size exclusion chromatography due to the absence of the DNA binding domain. LiaRN 
was subjected to phosphotransfer, to investigate whether the receiver domain was able to get 
phosphorylated to the same extent as full-length LiaR. The pseudo-first order rate constant for 
LiaRN was determined to be 0.0828 ± 0.0325 s-1, a value, significantly lower to that observed for 
the full-length protein. It is noteworthy that LiaS did not demonstrate phosphatase activity towards 
the receiver domain of LiaR, during the time intervals tested. This result was particularly intriguing 
because the HK and the RR often have a physical interaction aiding with the phosphotransfer and 
the subsequent phosphatase reaction. This interaction often occurs between the DHp domain of 
the HK and the α1 and α5 helices of the N-terminus of the RR (Leonard et al., 2013).   
Phosphorylation induced by acetyl phosphate on LiaRN was estimated to be 4 times slower when 
compared to the rate of phosphorylation of the full-length protein. Analytical ultracentrifugation 
experiments also indicated that LiaRN was fit for a monomer-dimer model. In its native state, the 
N-terminal domain was shown to exist as a monomer/dimer mixture using Native-PAGE analysis, 
suggesting that the regulatory domain switches between an active and inactive state when there is 
interaction with the effector domain. Our findings help rule out the possibility that LiaRN function 
as a standalone module (Galperin M. , 2010). 
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The variable C-terminal effector domain is mostly involved in DNA-binding and its structural 
variability contributes to a wide range of functional diversity. LiaR is said to belong to the LuxR-
type family of RRs, characterized by a conserved helix turn helix (HTH) motif. Structures of 
several LuxR-type (NarL family) have been resolved and shown that the DNA-binding domain is 
formed by a four-helix bundle (Barbieri et al., 2010). Surprisingly, LiaRC was unable to bind to 
the liaSR promoter as demonstrated by EMSA and DNase I footprinting assay.  The inability of 
LiaRC to bind to the DNA emphasizes the importance of the N-terminus for the formation of a 
stable structure and a conformational change necessary for LiaR’s binding to the gene promoter.  
The inability of LiaRC to bind DNA is atypical of the NarL family of RRs. Recent crystal structures 
of RRs belonging to the NarL/LuxR family have demonstrated that a distinct surface (α1-α5 
interface) is key in mediating phosphorylation-triggered dimerization. These α1-α5 helices are 
absent in LiaRC hence explaining the lack of dimerization and thereby DNA binding (Casino et 
al., 2010; Leonard et al., 2013). To my knowledge, only one study of DesR from B. subtilis (NarL 
family) has demonstrated similar results with respect to lack of binding to the DNA. 
Crystallography data on DesR indicates that phosphorylation of Asp54 induces significant 
rearrangements of residues Glu8, Asp9, Glu56, Thr80, and Thr81. This in turn, induces changes 
in protein folding, exposing the HTH motif that is responsible for DNA binding. Therefore, it is 
conceivable that the C-terminal domain of LiaR is unable to bind to DNA in the absence of 
phosphorylation on Asp54 (Trajtenberga et al., 2014). Although LiaR belongs to the NarL/LuxR 
family of RRs, it also shares a 28% sequence similarity to another distinct family of RRs 
(OmpR/PhoB family).  In this family of proteins, the phosphorylation of the N-terminus is essential 
for C-terminal DNA binding (Martinez-Hackert & Stock, 1997). It is thus plausible that the 
absence of the N-terminus from LiaR affects its ability to bind to DNA. 
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Recent studies have also put forth the notion of the “mutual inhibition” model of function for RRs. 
According to this model, there is bidirectional communication between the receiver and output 
domains. In 2016, Correa & Gardner demonstrated that the C-terminus can affect the structure and 
dynamics of the receiver domain (active and inactive state). Likewise, the N-terminus can affect 
the ability of the C-terminus to bind to DNA (Correa & Gardner, 2016). Since LiaRC was unable 
to bind DNA in the absence of the N-terminal domain and LiaRN demonstrated lesser 
phosphorylation in the absence of the C-terminus, my findings are compatible with the 
aforementioned “mutual inhibition” concept. 
My work also examined the interaction between the B. subtilis LiaSR and the well-characterized 
S. aureus VraSR TCSs.  LiaS and VraS are bifunctional HKs, meaning they both possess kinase 
and phosphatase activities. Interestingly, LiaR and VraR responded differently in the absence of 
their cognate sensors. The signal transfer from GST-VraS to LiaR was significantly faster in 
comparison to the cognate TCS (LiaS to LiaR) with a pseudo first order rate of 3.2129 ± 0.7339 s-
1. A sharp decline in phosphorylation of LiaR was also observed demonstrating, how VraS can 
serve as a more suitable phosphatase to LiaR than its cognate HK LiaS. These findings are contrary 
to the popular opinion that the domain alignment and physical bond formation between HKs and 
RRs are specific for cognate TCSs allowing for efficient signal transfer (Skerker et al., 2005; West 
& Stock, 2001). In contrast to the VraS and LiaR phosphotransfer reaction, VraR gets 
phosphorylated and maintains the phosphorylated state in the presence of LiaS as LiaS lacks 
phosphatase activity towards VraR. The structural similarities between LiaR and VraR were 
confirmed by DNase I footprinting showing LiaR binding to the vraSR gene promoter.  
Physical interactions between the homologous TCSs were analysed using pull down assays. The 
pull-down assay is an in vitro technique used for determining the physical interaction between two 
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or more proteins (Uzma Muzamal, 2014). The potential interaction between GST-LiaS/LiaR was 
examined where GST-LiaS served as the bait and LiaR as the prey. The results obtained indicated 
no physical interactions between these two components.  Next, we also determined if there a 
physical interaction between GST-VraS/LiaR and GST-LiaS/VraR since there was 
phosphotransfer observed in previous experiments.  Similarly, no physical interactions were 
evident. Finally, physical interactions between the homologous proteins GST-LiaS and His-VraS 
was analyzed, but did not observe any co-elution. However, we need to consider that the protein 
preparation contains many impurities which may have impacted the analysis of these experiments. 
In summary, my study provides novel insights into the molecular mechanisms of LiaSR-mediated 
signal transduction. Importantly, the truncated version of LiaS was shown to get phosphorylated 
in the presence of ATP in vitro. Furthermore, the bifunctional role of LiaS towards LiaR was 
addressed experimentally by determining the reaction rate constants. LiaR was shown to be 
phosphorylated by using acetyl phosphate, a small phospho-donor. WT-LiaR was shown to bind 
DNA strongly pre-and post phosphorylation as demonstrated by very small KD values in 
comparison to other RRs. Footprinting analysis demonstrated the existence of an additional DNA 
binding site for phosphorylated WT-LiaR on the liaSR gene promoter. Mutants of the C-terminus 
of LiaR, demonstrated similar oligomeric state and DNA binding behaviour in comparison to the 
WT protein. The N and the C-terminal domains of LiaR showed novel structural dependency on 
each other. When LiaSR was compared to the VraSR TCS by various in vitro techniques/assays 
differences were observed in phosphorylation and dephosphorylation rates. Hopefully the research 
shown here would contribute towards the recent advancements in structural and functional 
characterization of other TCSs in order to develop new antibiotics.  
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5 Future Directions 
My work provides important insights into the function and signaling mechanisms of the TCS in B. 
subtilis. However, there are a few interesting questions that require future investigation. For 
instance, it would be interesting to determine the exact binding location on the liaSR gene promoter 
where LiaR binds by using DNase I footprinting assay and the appropriate sequencing standards. 
Additionally, the LiaSR TCS is often associated with a third protein (LiaF), forming a three-
component system. In vivo studies have demonstrated that LiaF plays an inhibitory role in signal 
transduction between LiaS and LiaR. It would be interesting to study its involvement on signal 
transduction between LiaS and LiaR in vitro as well as its role in the ability of LiaR to bind to 
DNA. Studies have shown involvement of the vraT gene in the signal transduction from VraS to 
VraR. Similarly, the mechanisms by which VraT (homologous to LiaF) affects methicillin 
resistance are presently unclear (Boyle-Vavra et al., 2013). Studying the molecular characteristics 
of LiaF would contribute to understanding the signalling mechanisms operating in antibiotic 
resistant strains of S. aureus. A few studies have investigated the effect of ions (Mg+ and Ca2+) on 
signal transfer in TCSs (Patel & Golemi-Kotra, 2015). It would thus be interesting to determine 
whether ion concentration can influence (i.e. induce or inhibit) kinase activity (LiaS) or even 
modify the rate of phosphorylation for LiaR.  
The crystal structure of LiaRC from E. faecalis was used as a template for predicting the 
dimerization interface in its B. subtilis homolog. Unfortunately, the use of three full-length and C-
terminus mutants, did not allow for the characterization of the identity of the dimerization 
interface. Thus, an interesting alternative approach would require mutating amino acid residues on 
the N-terminus of LiaR, that may potentially be involved in the dimerization interface.  Because 
presently there is no crystal structure available for the N terminal domain of LiaR or its 
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homologues, it is hard to determine what exact amino acids are involved in dimer formation. 
Different crystallization conditions were tested by members of Dr. Vivian Saridakis lab in an 
attempt to crystallize the N-terminal domain of LiaR but with no success. Testing a variety of 
buffers and crystallization conditions and using BeF3- as a phosphate analog will help in solving 
the molecular architecture of phosphorylated and unphosphorylated LiaR.  
Although a lot of in vivo studies have been conducted on the TCS, a few questions still need to be 
addressed. For example, there is very little information regarding alterations in gene expression 
following binding of LiaR to the liaSR promoter, or the overall phenotypic changes post signaling. 
Finally, investigation of the effect of LiaR deletion on the function and integrity of the cell wall 
by techniques such as NMR and electron microscopy can help address important questions relating 
to antimicrobial resistance. 
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APPENDICES 
Appendix A: DNA sequencing results for GST-LiaSAla126, GST-LiaSArg153, GST-LiaSH159A, 
LiaRD54A, LiaR T198A, LiaR V202A, LiaR H205A, LiaRN, LiaRC, LiaRC T198A, LiaRC 
V202A and LiaRC H205A 
i) GST-LiaS Ala126  
The sequence of GST-LiaS was amplified from the full-length gene from amino acids residues 126 
to 360, shown by the bolded letters. With a total of 708 base pairs. 
MRKKMLASLQWRAIRMTTGISLLLFVCLISFMMFYYRLDPLVLLSSSWFGIPFILILLLISV
TVGFASGYMYGNRLKTRIDTLIESILTFENGNFAYRIPPLGDDEIGLAADQLNEMAKRVE
LQVASLQKLSNERAEWQAQMKKSVISEERQRLARDLHDAVSQQLFAISMMTSAVL
EHVKDADDKTVKRIRMVEHMAGEAQNEMRALLLHLRPVTLEGKGLKEGLTELLD
EFRKKQPIDIEWDIQDTAISKGVEDHLFRIVQEALSNVFRHSKASKVTVILGIKNSQL
RLKVIDNGKGFKMDQVKASSYGLNSMKERASEIGGVAEVISVEGKGTQIEVKVPIF
PEEKGENERDSSIID 
Score Expect Identities Gaps Strand 
1308 bits(708) 0.0 708/708(100%) 0/708(0%) Plus/Plus 
Query  1    GCATCCCTCCAGAAACTTTCCAATGAACGTGCGGAATGGCAGGCTCAAATGAAGAAGTCG  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    GCATCCCTCCAGAAACTTTCCAATGAACGTGCGGAATGGCAGGCTCAAATGAAGAAGTCG  60 
 
Query  61   GTTATCTCAGAAGAACGCCAGCGATTGGCCAGAGATCTTCATGATGCGGTCAGCCAGCAG  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   GTTATCTCAGAAGAACGCCAGCGATTGGCCAGAGATCTTCATGATGCGGTCAGCCAGCAG  120 
 
Query  121  CTCTTTGCCATATCGATGATGACATCAGCCGTGCTGGAACATGTCAAGGATGCTGATGAC  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  CTCTTTGCCATATCGATGATGACATCAGCCGTGCTGGAACATGTCAAGGATGCTGATGAC  180 
 
Query  181  AAAACAGTCAAGCGGATCAGGATGGTCGAGCATATGGCAGGCGAAGCCCAAAATGAGATG  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  AAAACAGTCAAGCGGATCAGGATGGTCGAGCATATGGCAGGCGAAGCCCAAAATGAGATG  240 
 
Query  241  AGGGCGCTGCTGCTCCATTTACGGCCTGTTACCCTTGAAGGAAAAGGGCTGAAGGAGGGC  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  AGGGCGCTGCTGCTCCATTTACGGCCTGTTACCCTTGAAGGAAAAGGGCTGAAGGAGGGC  300 
 
Query  301  CTTACGGAGCTTTTGGACGAGTTCCGAAAAAAGCAGCCGATTGATATTGAGTGGGATATA  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  CTTACGGAGCTTTTGGACGAGTTCCGAAAAAAGCAGCCGATTGATATTGAGTGGGATATA  360 
 
Query  361  CAGGACACAGCGATATCCAAGGGTGTTGAAGACCACTTGTTCAGAATCGTGCAGGAGGCC  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  CAGGACACAGCGATATCCAAGGGTGTTGAAGACCACTTGTTCAGAATCGTGCAGGAGGCC  420 
 
Query  421  CTTTCAAACGTATTTAGACATTCAAAAGCGTCAAAAGTAACCGTGATTCTGGGCATAAAG  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  CTTTCAAACGTATTTAGACATTCAAAAGCGTCAAAAGTAACCGTGATTCTGGGCATAAAG  480 
 
Query  481  AACAGCCAGCTCCGTCTGAAGGTGATTGATAATGGAAAAGGCTTTAAAATGGACCAGGTG  540 
 111 
 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  AACAGCCAGCTCCGTCTGAAGGTGATTGATAATGGAAAAGGCTTTAAAATGGACCAGGTG  540 
 
Query  541  AAAGCCTCCTCATACGGCTTGAATTCTATGAAAGAACGTGCAAGTGAAATCGGCGGTGTC  600 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  541  AAAGCCTCCTCATACGGCTTGAATTCTATGAAAGAACGTGCAAGTGAAATCGGCGGTGTC  600 
 
Query  601  GCCGAAGTGATTTCAGTAGAAGGAAAAGGCACTCAAATCGAAGTGAAGGTCCCGATTTTT  660 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  601  GCCGAAGTGATTTCAGTAGAAGGAAAAGGCACTCAAATCGAAGTGAAGGTCCCGATTTTT  660 
 
Query  661  CCGGAAGAAAAAGGAGAGAACGAACGTGATTCGAGTATTATTGATTGA  708 
            |||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  661  CCGGAAGAAAAAGGAGAGAACGAACGTGATTCGAGTATTATTGATTGA  708 
 
ii) GST-LiaSArg153 
The sequence of GST-LiaS was amplified from the full-length gene from amino acids residues 153 
to 360, shown by the bolded letters. With a total of 627 base pairs. 
MRKKMLASLQWRAIRMTTGISLLLFVCLISFMMFYYRLDPLVLLSSSWFGIPFILILLLISV
TVGFASGYMYGNRLKTRIDTLIESILTFENGNFAYRIPPLGDDEIGLAADQLNEMAKRVE
LQVASLQKLSNERAEWQAQMKKSVISEERQRLARDLHDAVSQQLFAISMMTSAVLE
HVKDADDKTVKRIRMVEHMAGEAQNEMRALLLHLRPVTLEGKGLKEGLTELLDE
FRKKQPIDIEWDIQDTAISKGVEDHLFRIVQEALSNVFRHSKASKVTVILGIKNSQLR
LKVIDNGKGFKMDQVKASSYGLNSMKERASEIGGVAEVISVEGKGTQIEVKVPIFP
EEKGENERDSSIID 
 
 
Query  1    CGATTGGCCAGAGATCTTCATGATGCGGTCAGCCAGCAGCTCTTTGCCATATCGATGATG  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    CGATTGGCCAGAGATCTTCATGATGCGGTCAGCCAGCAGCTCTTTGCCATATCGATGATG  60 
 
Query  61   ACATCAGCCGTGCTGGAACATGTCAAGGATGCTGATGACAAAACAGTCAAGCGGATCAGG  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   ACATCAGCCGTGCTGGAACATGTCAAGGATGCTGATGACAAAACAGTCAAGCGGATCAGG  120 
 
Query  121  ATGGTCGAGCATATGGCAGGCGAAGCCCAAAATGAGATGAGGGCGCTGCTGCTCCATTTA  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  ATGGTCGAGCATATGGCAGGCGAAGCCCAAAATGAGATGAGGGCGCTGCTGCTCCATTTA  180 
 
Query  181  CGGCCTGTTACCCTTGAAGGAAAAGGGCTGAAGGAGGGCCTTACGGAGCTTTTGGACGAG  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  CGGCCTGTTACCCTTGAAGGAAAAGGGCTGAAGGAGGGCCTTACGGAGCTTTTGGACGAG  240 
 
Query  241  TTCCGAAAAAAGCAGCCGATTGATATTGAGTGGGATATACAGGACACAGCGATATCCAAG  300 
Score Expect Identities Gaps Strand 
1158 bits(627) 0.0 627/627(100%) 0/627(0%) Plus/Plus 
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            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  TTCCGAAAAAAGCAGCCGATTGATATTGAGTGGGATATACAGGACACAGCGATATCCAAG  300 
 
Query  301  GGTGTTGAAGACCACTTGTTCAGAATCGTGCAGGAGGCCCTTTCAAACGTATTTAGACAT  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  GGTGTTGAAGACCACTTGTTCAGAATCGTGCAGGAGGCCCTTTCAAACGTATTTAGACAT  360 
 
Query  361  TCAAAAGCGTCAAAAGTAACCGTGATTCTGGGCATAAAGAACAGCCAGCTCCGTCTGAAG  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  TCAAAAGCGTCAAAAGTAACCGTGATTCTGGGCATAAAGAACAGCCAGCTCCGTCTGAAG  420 
 
Query  421  GTGATTGATAATGGAAAAGGCTTTAAAATGGACCAGGTGAAAGCCTCCTCATACGGCTTG  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  GTGATTGATAATGGAAAAGGCTTTAAAATGGACCAGGTGAAAGCCTCCTCATACGGCTTG  480 
 
Query  481  AATTCTATGAAAGAACGTGCAAGTGAAATCGGCGGTGTCGCCGAAGTGATTTCAGTAGAA  540 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  AATTCTATGAAAGAACGTGCAAGTGAAATCGGCGGTGTCGCCGAAGTGATTTCAGTAGAA  540 
 
Query  541  GGAAAAGGCACTCAAATCGAAGTGAAGGTCCCGATTTTTCCGGAAGAAAAAGGAGAGAAC  600 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  541  GGAAAAGGCACTCAAATCGAAGTGAAGGTCCCGATTTTTCCGGAAGAAAAAGGAGAGAAC  600 
 
Query  601  GAACGTGATTCGAGTATTATTGATTGA  627 
            ||||||||||||||||||||||||||| 
Sbjct  601  GAACGTGATTCGAGTATTATTGATTGA  627 
 
iii) GST-LiaS H159A 
GST LiaSAla126 was used as template to mutate the histidine residue on position 159, shown 
in red. 
ASLQKLSNERAEWQAQMKKSVISEERQRLARDLHDAVSQQLFAISMMTSAVLEHV
KDADDKTVKRIRMVEHMAGEAQNEMRALLLHLRPVTLEGKGLKEGLTELLDEFR
KKQPIDIEWDIQDTAISKGVEDHLFRIVQEALSNVFRHSKASKVTVILGIKNSQLRLK
VIDNGKGFKMDQVKASSYGLNSMKERASEIGGVAEVISVEGKGTQIEVKVPIFPEE
KGENERDSSIID 
 
Histidine 159 was mutated to Alanine 
 
Query  1    CGCATCCCTCCAGAAACTTTCCAATGAACGTGCGGAATGGCAGGCTCAAATGAAGAAGTC  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Score Expect Identities Gaps Strand 
1299 bits(703) 0.0 707/709(99%) 0/709(0%) Plus/Plus 
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Sbjct  1    CGCATCCCTCCAGAAACTTTCCAATGAACGTGCGGAATGGCAGGCTCAAATGAAGAAGTC  60 
 
Query  61   GGTTATCTCAGAAGAACGCCAGCGATTGGCCAGAGATCTTGCTGATGCGGTCAGCCAGCA  120 
            ||||||||||||||||||||||||||||||||||||||||  |||||||||||||||||| 
Sbjct  61   GGTTATCTCAGAAGAACGCCAGCGATTGGCCAGAGATCTTCATGATGCGGTCAGCCAGCA  120 
 
Query  121  GCTCTTTGCCATATCGATGATGACATCAGCCGTGCTGGAACATGTCAAGGATGCTGATGA  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  GCTCTTTGCCATATCGATGATGACATCAGCCGTGCTGGAACATGTCAAGGATGCTGATGA  180 
 
Query  181  CAAAACAGTCAAGCGGATCAGGATGGTCGAGCATATGGCAGGCGAAGCCCAAAATGAGAT  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  CAAAACAGTCAAGCGGATCAGGATGGTCGAGCATATGGCAGGCGAAGCCCAAAATGAGAT  240 
 
Query  241  GAGGGCGCTGCTGCTCCATTTACGGCCTGTTACCCTTGAAGGAAAAGGGCTGAAGGAGGG  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  GAGGGCGCTGCTGCTCCATTTACGGCCTGTTACCCTTGAAGGAAAAGGGCTGAAGGAGGG  300 
 
Query  301  CCTTACGGAGCTTTTGGACGAGTTCCGAAAAAAGCAGCCGATTGATATTGAGTGGGATAT  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  CCTTACGGAGCTTTTGGACGAGTTCCGAAAAAAGCAGCCGATTGATATTGAGTGGGATAT  360 
 
Query  361  ACAGGACACAGCGATATCCAAGGGTGTTGAAGACCACTTGTTCAGAATCGTGCAGGAGGC  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  ACAGGACACAGCGATATCCAAGGGTGTTGAAGACCACTTGTTCAGAATCGTGCAGGAGGC  420 
 
Query  421  CCTTTCAAACGTATTTAGACATTCAAAAGCGTCAAAAGTAACCGTGATTCTGGGCATAAA  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  CCTTTCAAACGTATTTAGACATTCAAAAGCGTCAAAAGTAACCGTGATTCTGGGCATAAA  480 
 
Query  481  GAACAGCCAGCTCCGTCTGAAGGTGATTGATAATGGAAAAGGCTTTAAAATGGACCAGGT  540 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  GAACAGCCAGCTCCGTCTGAAGGTGATTGATAATGGAAAAGGCTTTAAAATGGACCAGGT  540 
 
Query  541  GAAAGCCTCCTCATACGGCTTGAATTCTATGAAAGAACGTGCAAGTGAAATCGGCGGTGT  600 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  541  GAAAGCCTCCTCATACGGCTTGAATTCTATGAAAGAACGTGCAAGTGAAATCGGCGGTGT  600 
 
Query  601  CGCCGAAGTGATTTCAGTAGAAGGAAAAGGCACTCAAATCGAAGTGAAGGTCCCGATTTT  660 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  601  CGCCGAAGTGATTTCAGTAGAAGGAAAAGGCACTCAAATCGAAGTGAAGGTCCCGATTTT  660 
 
Query  661  TCCGGAAGAAAAAGGAGAGAACGAACGTGATTCGAGTATTATTGATTGA  709 
            ||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  661  TCCGGAAGAAAAAGGAGAGAACGAACGTGATTCGAGTATTATTGATTGA  709 
 
iv) LiaR D54A 
WT-LiaR was used as the template for mutating the aspartate residue at position 54, to alanine. 
MIRVLLIDDHEMVRMGLAAFLEAQPDIEVIGEASDGSEGVRLAVELSPDVILMDLVMEG
MDGIEATKQICRELSDPKIIVLTSFIDDDKVYPVIEAGALSYLLKTSKAAEIADAIRAASK 
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GEPKLESKVAGKVLSRLRHSGENALPHESLTKRELEILCLIAEGKTNKEIGEELFITIKTVK
THITNILSKLDVSDRTQAAVYAHRNHLVN 
Aspartate 54 was mutated to Alanine 
Score Expect Identities Gaps Strand 
1168 bits(632) 0.0 634/635(99%) 0/635(0%) Plus/Plus 
Query  2    TGATTCGAGTATTATTGATTGATGATCATGAAATGGTCAGAATGGGGCTCGCGGCTTTTT  61 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  2    TGATTCGAGTATTATTGATTGATGATCATGAAATGGTCAGAATGGGGCTCGCGGCTTTTT  61 
 
Query  62   TGGAGGCGCAGCCCGATATTGAAGTCATCGGCGAAGCATCGGACGGCAGCGAAGGTGTTC  121 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  62   TGGAGGCGCAGCCCGATATTGAAGTCATCGGCGAAGCATCGGACGGCAGCGAAGGTGTTC  121 
 
Query  122  GGCTTGCTGTGGAACTGTCGCCTGATGTCATTTTAATGGACCTTGTCATGGAGGGCATGG  181 
            ||||||||||||||||||||||||||||||||||||||| |||||||||||||||||||| 
Sbjct  122  GGCTTGCTGTGGAACTGTCGCCTGATGTCATTTTAATGGCCCTTGTCATGGAGGGCATGG  181 
 
Query  182  ATGGCATTGAAGCTACAAAGCAAATTTGCCGGGAGCTTTCCGACCCGAAAATTATTGTGC  241 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  182  ATGGCATTGAAGCTACAAAGCAAATTTGCCGGGAGCTTTCCGACCCGAAAATTATTGTGC  241 
 
Query  242  TCACTAGCTTCATTGATGATGACAAAGTGTACCCGGTTATTGAAGCTGGCGCGCTCAGCT  301 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  242  TCACTAGCTTCATTGATGATGACAAAGTGTACCCGGTTATTGAAGCTGGCGCGCTCAGCT  301 
 
Query  302  ATCTGTTGAAAACCTCAAAAGCGGCAGAAATCGCCGATGCCATCCGCGCCGCAAGCAAGG  361 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  302  ATCTGTTGAAAACCTCAAAAGCGGCAGAAATCGCCGATGCCATCCGCGCCGCAAGCAAGG  361 
 
Query  362  GAGAGCCGAAGCTGGAGTCAAAAGTGGCGGGAAAAGTATTATCCAGGCTGCGCCACTCAG  421 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  362  GAGAGCCGAAGCTGGAGTCAAAAGTGGCGGGAAAAGTATTATCCAGGCTGCGCCACTCAG  421 
 
Query  422  GTGAAAACGCGCTCCCGCATGAATCGCTTACAAAACGGGAGCTCGAAATACTCTGCCTGA  481 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  422  GTGAAAACGCGCTCCCGCATGAATCGCTTACAAAACGGGAGCTCGAAATACTCTGCCTGA  481 
 
Query  482  TCGCAGAAGGAAAGACAAACAAAGAAATAGGCGAGGAACTGTTTATTACGATTAAAACAG  541 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  482  TCGCAGAAGGAAAGACAAACAAAGAAATAGGCGAGGAACTGTTTATTACGATTAAAACAG  541 
 
Query  542  TCAAAACACATATTACGAATATTTTATCAAAGCTGGATGTCAGTGACCGGACGCAGGCGG  601 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  542  TCAAAACACATATTACGAATATTTTATCAAAGCTGGATGTCAGTGACCGGACGCAGGCGG  601 
 
Query  602  CGGTGTACGCACACCGAAATCATCTCGTGAATTAG  636 
            ||||||||||||||||||||||||||||||||||| 
Sbjct  602  CGGTGTACGCACACCGAAATCATCTCGTGAATTAG  636 
 
 
 115 
 
v) LiaR T198A 
WT-LiaR was used as the template for mutating the threonine residue at position 198, to alanine. 
MIRVLLIDDHEMVRMGLAAFLEAQPDIEVIGEASDGSEGVRLAVELSPDVILMDLVMEG
MDGIEATKQICRELSDPKIIVLTSFIDDDKVYPVIEAGALSYLLKTSKAAEIADAIRAASK 
GEPKLESKVAGKVLSRLRHSGENALPHESLTKRELEILCLIAEGKTNKEIGEELFITIKTVK
THITNILSKLDVSDRTQAAVYAHRNHLVN 
Threonine was mutated to Alanine 
Score Expect Identities Gaps Strand 
1170 bits(633) 0.0 635/636(99%) 0/636(0%) Plus/Plus 
Query  1    ATGATTCGAGTATTATTGATTGATGATCATGAAATGGTCAGAATGGGGCTCGCGGCTTTT  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    ATGATTCGAGTATTATTGATTGATGATCATGAAATGGTCAGAATGGGGCTCGCGGCTTTT  60 
 
Query  61   TTGGAGGCGCAGCCCGATATTGAAGTCATCGGCGAAGCATCGGACGGCAGCGAAGGTGTT  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   TTGGAGGCGCAGCCCGATATTGAAGTCATCGGCGAAGCATCGGACGGCAGCGAAGGTGTT  120 
 
Query  121  CGGCTTGCTGTGGAACTGTCGCCTGATGTCATTTTAATGGACCTTGTCATGGAGGGCATG  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  CGGCTTGCTGTGGAACTGTCGCCTGATGTCATTTTAATGGACCTTGTCATGGAGGGCATG  180 
 
Query  181  GATGGCATTGAAGCTACAAAGCAAATTTGCCGGGAGCTTTCCGACCCGAAAATTATTGTG  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  GATGGCATTGAAGCTACAAAGCAAATTTGCCGGGAGCTTTCCGACCCGAAAATTATTGTG  240 
 
Query  241  CTCACTAGCTTCATTGATGATGACAAAGTGTACCCGGTTATTGAAGCTGGCGCGCTCAGC  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  CTCACTAGCTTCATTGATGATGACAAAGTGTACCCGGTTATTGAAGCTGGCGCGCTCAGC  300 
 
Query  301  TATCTGTTGAAAACCTCAAAAGCGGCAGAAATCGCCGATGCCATCCGCGCCGCAAGCAAG  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  TATCTGTTGAAAACCTCAAAAGCGGCAGAAATCGCCGATGCCATCCGCGCCGCAAGCAAG  360 
 
Query  361  GGAGAGCCGAAGCTGGAGTCAAAAGTGGCGGGAAAAGTATTATCCAGGCTGCGCCACTCA  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  GGAGAGCCGAAGCTGGAGTCAAAAGTGGCGGGAAAAGTATTATCCAGGCTGCGCCACTCA  420 
 
Query  421  GGTGAAAACGCGCTCCCGCATGAATCGCTTACAAAACGGGAGCTCGAAATACTCTGCCTG  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  GGTGAAAACGCGCTCCCGCATGAATCGCTTACAAAACGGGAGCTCGAAATACTCTGCCTG  480 
 
Query  481  ATCGCAGAAGGAAAGACAAACAAAGAAATAGGCGAGGAACTGTTTATTACGATTAAAACA  540 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  ATCGCAGAAGGAAAGACAAACAAAGAAATAGGCGAGGAACTGTTTATTACGATTAAAACA  540 
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Query  541  GTCAAAACACATATTACGAATATTTTATCAAAGCTGGATGTCAGTGACCGGACGCAGGCG  600 
            ||||||||||||||||||||||||||||||||||||||||||||||||||| |||||||| 
Sbjct  541  GTCAAAACACATATTACGAATATTTTATCAAAGCTGGATGTCAGTGACCGGGCGCAGGCG  600 
 
Query  601  GCGGTGTACGCACACCGAAATCATCTCGTGAATTAG  636 
            |||||||||||||||||||||||||||||||||||| 
Sbjct  601  GCGGTGTACGCACACCGAAATCATCTCGTGAATTAG  636 
 
vi) LiaR V202A 
WT-LiaR was used as the template for mutating the valine residue at position 202, to alanine. 
MIRVLLIDDHEMVRMGLAAFLEAQPDIEVIGEASDGSEGVRLAVELSPDVILMDLVMEG
MDGIEATKQICRELSDPKIIVLTSFIDDDKVYPVIEAGALSYLLKTSKAAEIADAIRAASK 
GEPKLESKVAGKVLSRLRHSGENALPHESLTKRELEILCLIAEGKTNKEIGEELFITIKTVK
THITNILSKLDVSDRTQAAVYAHRNHLVN 
Valine was mutated to Alanine 
Score Expect Identities Gaps Strand 
1170 bits(633) 0.0 635/636(99%) 0/636(0%) Plus/Plus 
Query  1    ATGATTCGAGTATTATTGATTGATGATCATGAAATGGTCAGAATGGGGCTCGCGGCTTTT  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    ATGATTCGAGTATTATTGATTGATGATCATGAAATGGTCAGAATGGGGCTCGCGGCTTTT  60 
 
Query  61   TTGGAGGCGCAGCCCGATATTGAAGTCATCGGCGAAGCATCGGACGGCAGCGAAGGTGTT  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   TTGGAGGCGCAGCCCGATATTGAAGTCATCGGCGAAGCATCGGACGGCAGCGAAGGTGTT  120 
 
Query  121  CGGCTTGCTGTGGAACTGTCGCCTGATGTCATTTTAATGGACCTTGTCATGGAGGGCATG  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  CGGCTTGCTGTGGAACTGTCGCCTGATGTCATTTTAATGGACCTTGTCATGGAGGGCATG  180 
 
Query  181  GATGGCATTGAAGCTACAAAGCAAATTTGCCGGGAGCTTTCCGACCCGAAAATTATTGTG  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  GATGGCATTGAAGCTACAAAGCAAATTTGCCGGGAGCTTTCCGACCCGAAAATTATTGTG  240 
 
Query  241  CTCACTAGCTTCATTGATGATGACAAAGTGTACCCGGTTATTGAAGCTGGCGCGCTCAGC  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  CTCACTAGCTTCATTGATGATGACAAAGTGTACCCGGTTATTGAAGCTGGCGCGCTCAGC  300 
 
Query  301  TATCTGTTGAAAACCTCAAAAGCGGCAGAAATCGCCGATGCCATCCGCGCCGCAAGCAAG  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  TATCTGTTGAAAACCTCAAAAGCGGCAGAAATCGCCGATGCCATCCGCGCCGCAAGCAAG  360 
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Query  361  GGAGAGCCGAAGCTGGAGTCAAAAGTGGCGGGAAAAGTATTATCCAGGCTGCGCCACTCA  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  GGAGAGCCGAAGCTGGAGTCAAAAGTGGCGGGAAAAGTATTATCCAGGCTGCGCCACTCA  420 
 
Query  421  GGTGAAAACGCGCTCCCGCATGAATCGCTTACAAAACGGGAGCTCGAAATACTCTGCCTG  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  GGTGAAAACGCGCTCCCGCATGAATCGCTTACAAAACGGGAGCTCGAAATACTCTGCCTG  480 
 
Query  481  ATCGCAGAAGGAAAGACAAACAAAGAAATAGGCGAGGAACTGTTTATTACGATTAAAACA  540 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  ATCGCAGAAGGAAAGACAAACAAAGAAATAGGCGAGGAACTGTTTATTACGATTAAAACA  540 
 
Query  541  GTCAAAACACATATTACGAATATTTTATCAAAGCTGGATGTCAGTGACCGGACGCAGGCG  600 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  541  GTCAAAACACATATTACGAATATTTTATCAAAGCTGGATGTCAGTGACCGGACGCAGGCG  600 
 
Query  601  GCGGTGTACGCACACCGAAATCATCTCGTGAATTAG  636 
            |||| ||||||||||||||||||||||||||||||| 
Sbjct  601  GCGGCGTACGCACACCGAAATCATCTCGTGAATTAG  636 
 
 
vii) LiaR H205A 
WT-LiaR was used as the template for mutating the histidine residue at position 205, to alanine. 
MIRVLLIDDHEMVRMGLAAFLEAQPDIEVIGEASDGSEGVRLAVELSPDVILMDLVMEG
MDGIEATKQICRELSDPKIIVLTSFIDDDKVYPVIEAGALSYLLKTSKAAEIADAIRAASK 
GEPKLESKVAGKVLSRLRHSGENALPHESLTKRELEILCLIAEGKTNKEIGEELFITIKTVK
THITNILSKLDVSDRTQAAVYAHRNHLVN 
Histidine was mutated to Alanine 
Score Expect Identities Gaps Strand 
1164 bits(630) 0.0 634/636(99%) 0/636(0%) Plus/Plus 
Query  1    ATGATTCGAGTATTATTGATTGATGATCATGAAATGGTCAGAATGGGGCTCGCGGCTTTT  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    ATGATTCGAGTATTATTGATTGATGATCATGAAATGGTCAGAATGGGGCTCGCGGCTTTT  60 
 
Query  61   TTGGAGGCGCAGCCCGATATTGAAGTCATCGGCGAAGCATCGGACGGCAGCGAAGGTGTT  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   TTGGAGGCGCAGCCCGATATTGAAGTCATCGGCGAAGCATCGGACGGCAGCGAAGGTGTT  120 
 
Query  121  CGGCTTGCTGTGGAACTGTCGCCTGATGTCATTTTAATGGACCTTGTCATGGAGGGCATG  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  CGGCTTGCTGTGGAACTGTCGCCTGATGTCATTTTAATGGACCTTGTCATGGAGGGCATG  180 
 
Query  181  GATGGCATTGAAGCTACAAAGCAAATTTGCCGGGAGCTTTCCGACCCGAAAATTATTGTG  240 
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            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  GATGGCATTGAAGCTACAAAGCAAATTTGCCGGGAGCTTTCCGACCCGAAAATTATTGTG  240 
 
Query  241  CTCACTAGCTTCATTGATGATGACAAAGTGTACCCGGTTATTGAAGCTGGCGCGCTCAGC  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  CTCACTAGCTTCATTGATGATGACAAAGTGTACCCGGTTATTGAAGCTGGCGCGCTCAGC  300 
 
Query  301  TATCTGTTGAAAACCTCAAAAGCGGCAGAAATCGCCGATGCCATCCGCGCCGCAAGCAAG  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  TATCTGTTGAAAACCTCAAAAGCGGCAGAAATCGCCGATGCCATCCGCGCCGCAAGCAAG  360 
 
Query  361  GGAGAGCCGAAGCTGGAGTCAAAAGTGGCGGGAAAAGTATTATCCAGGCTGCGCCACTCA  420 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  GGAGAGCCGAAGCTGGAGTCAAAAGTGGCGGGAAAAGTATTATCCAGGCTGCGCCACTCA  420 
 
Query  421  GGTGAAAACGCGCTCCCGCATGAATCGCTTACAAAACGGGAGCTCGAAATACTCTGCCTG  480 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  GGTGAAAACGCGCTCCCGCATGAATCGCTTACAAAACGGGAGCTCGAAATACTCTGCCTG  480 
 
Query  481  ATCGCAGAAGGAAAGACAAACAAAGAAATAGGCGAGGAACTGTTTATTACGATTAAAACA  540 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  ATCGCAGAAGGAAAGACAAACAAAGAAATAGGCGAGGAACTGTTTATTACGATTAAAACA  540 
 
Query  541  GTCAAAACACATATTACGAATATTTTATCAAAGCTGGATGTCAGTGACCGGACGCAGGCG  600 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  541  GTCAAAACACATATTACGAATATTTTATCAAAGCTGGATGTCAGTGACCGGACGCAGGCG  600 
 
Query  601  GCGGTGTACGCACACCGAAATCATCTCGTGAATTAG  636 
            ||||||||||||  |||||||||||||||||||||| 
Sbjct  601  GCGGTGTACGCAGCCCGAAATCATCTCGTGAATTAG  636 
 
viii) LiaRN 
WT-LiaR was used as the template for mutating the glycine residue at position 131, to stop codon. 
The bolded sequence shows the N-terminal LiaR sequence 1-131. 
MIRVLLIDDHEMVRMGLAAFLEAQPDIEVIGEASDGSEGVRLAVELSPDVILMDLV
MEGMDGIEATKQICRELSDPKIIVLTSFIDDDKVYPVIEAGALSYLLKTSKAAEIADA
IRAASKGEPKLESKVA*G*KVLSRLRHSGENALPHESLTKRELEILCLIAEGKTNKEIGEE
LFITIKTVKTHITNILSKLDVSDRTQAAVYAHRNHLVN 
Glycine was mutated to stop codon 
Score Expect Identities Gaps Strand 
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726 bits(393) 0.0 395/393(99%) 0/396(0%) Plus/Plus 
Query  1    ATGATTCGAGTATTATTGATTGATGATCATGAAATGGTCAGAATGGGGCTCGCGGCTTTT  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    ATGATTCGAGTATTATTGATTGATGATCATGAAATGGTCAGAATGGGGCTCGCGGCTTTT  60 
 
Query  61   TTGGAGGCGCAGCCCGATATTGAAGTCATCGGCGAAGCATCGGACGGCAGCGAAGGTGTT  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   TTGGAGGCGCAGCCCGATATTGAAGTCATCGGCGAAGCATCGGACGGCAGCGAAGGTGTT  120 
 
Query  121  CGGCTTGCTGTGGAACTGTCGCCTGATGTCATTTTAATGGACCTTGTCATGGAGGGCATG  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  CGGCTTGCTGTGGAACTGTCGCCTGATGTCATTTTAATGGACCTTGTCATGGAGGGCATG  180 
 
Query  181  GATGGCATTGAAGCTACAAAGCAAATTTGCCGGGAGCTTTCCGACCCGAAAATTATTGTG  240 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  GATGGCATTGAAGCTACAAAGCAAATTTGCCGGGAGCTTTCCGACCCGAAAATTATTGTG  240 
 
Query  241  CTCACTAGCTTCATTGATGATGACAAAGTGTACCCGGTTATTGAAGCTGGCGCGCTCAGC  300 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  CTCACTAGCTTCATTGATGATGACAAAGTGTACCCGGTTATTGAAGCTGGCGCGCTCAGC  300 
 
Query  301  TATCTGTTGAAAACCTCAAAAGCGGCAGAAATCGCCGATGCCATCCGCGCCGCAAGCAAG  360 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  TATCTGTTGAAAACCTCAAAAGCGGCAGAAATCGCCGATGCCATCCGCGCCGCAAGCAAG  360 
 
Query  361  GGAGAGCCGAAGCTGGAGTCAAAAGTGGCGGGA  393 
            |||||||||||||||||||||||||||||| || 
Sbjct  361  GGAGAGCCGAAGCTGGAGTCAAAAGTGGCGTGA  393 
 
ix) LiaRC 
WT-LiaR was used as the template for amplifying the C-terminal. The LiaRC sequence is bolded 
with just 73 amino acids. 
MIRVLLIDDHEMVRMGLAAFLEAQPDIEVIGEASDGSEGVRLAVELSPDVILMDLVMEG
MDGIEATKQICRELSDPKIIVLTSFIDDDKVYPVIEAGALSYLLKTSKAAEIADAIRAASK 
 120 
 
GEPKLESKVAGKVLSRLRHSGENALPHESLTKRELEILCLIAEGKTNKEIGEELFITIK
TVKTHITNILSKLDVSDRTQAAVYAHRNHLVN 
Score Expect Identities Gaps Strand 
405 bits(219) 5e-118 219/219(100%) 0/219(0%) Plus/Plus 
Query  1    TCAGGTGAAAACGCGCTCCCGCATGAATCGCTTACAAAACGGGAGCTCGAAATACTCTGC  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    TCAGGTGAAAACGCGCTCCCGCATGAATCGCTTACAAAACGGGAGCTCGAAATACTCTGC  60 
 
Query  61   CTGATCGCAGAAGGAAAGACAAACAAAGAAATAGGCGAGGAACTGTTTATTACGATTAAA  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   CTGATCGCAGAAGGAAAGACAAACAAAGAAATAGGCGAGGAACTGTTTATTACGATTAAA  120 
 
Query  121  ACAGTCAAAACACATATTACGAATATTTTATCAAAGCTGGATGTCAGTGACCGGACGCAG  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  ACAGTCAAAACACATATTACGAATATTTTATCAAAGCTGGATGTCAGTGACCGGACGCAG  180 
 
Query  181  GCGGCGGTGTACGCACACCGAAATCATCTCGTGAATTAG  219 
            ||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  GCGGCGGTGTACGCACACCGAAATCATCTCGTGAATTAG  219 
 
x) LiaRC T198A 
WT-LiaRC was used as the template for mutating the threonine residue at position 198, to alanine. 
SGENALPHESLTKRELEILCLIAEGKTNKEIGEELFITIKTVKTHITNILSKLDVSDRT
QAAVYAHRNHLVN 
Threonine mutated to Alanine 
-Score Expect Identities Gaps Strand 
399 bits(216) 2e-116 218/219(99%) 0/219(0%) Plus/Plus 
Query  1    TCAGGTGAAAACGCGCTCCCGCATGAATCGCTTACAAAACGGGAGCTCGAAATACTCTGC  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    TCAGGTGAAAACGCGCTCCCGCATGAATCGCTTACAAAACGGGAGCTCGAAATACTCTGC  60 
 
Query  61   CTGATCGCAGAAGGAAAGACAAACAAAGAAATAGGCGAGGAACTGTTTATTACGATTAAA  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   CTGATCGCAGAAGGAAAGACAAACAAAGAAATAGGCGAGGAACTGTTTATTACGATTAAA  120 
 
Query  121  ACAGTCAAAACACATATTACGAATATTTTATCAAAGCTGGATGTCAGTGACCGGACGCAG  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||| ||||| 
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Sbjct  121  ACAGTCAAAACACATATTACGAATATTTTATCAAAGCTGGATGTCAGTGACCGGGCGCAG  180 
 
Query  181  GCGGCGGTGTACGCACACCGAAATCATCTCGTGAATTAG  219 
            ||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  GCGGCGGTGTACGCACACCGAAATCATCTCGTGAATTAG  219 
 
xi) LiaRC V202A 
WT-LiaRC was used as the template for mutating the valine residue at position 202, to alanine. 
SGENALPHESLTKRELEILCLIAEGKTNKEIGEELFITIKTVKTHITNILSKLDVSDRT
QAAVYAHRNHLVN 
Valine mutated to Alanine 
Score Expect Identities Gaps Strand 
399 bits(216) 2e-116 218/219(99%) 0/219(0%) Plus/Plus 
Query  1    TCAGGTGAAAACGCGCTCCCGCATGAATCGCTTACAAAACGGGAGCTCGAAATACTCTGC  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    TCAGGTGAAAACGCGCTCCCGCATGAATCGCTTACAAAACGGGAGCTCGAAATACTCTGC  60 
 
Query  61   CTGATCGCAGAAGGAAAGACAAACAAAGAAATAGGCGAGGAACTGTTTATTACGATTAAA  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   CTGATCGCAGAAGGAAAGACAAACAAAGAAATAGGCGAGGAACTGTTTATTACGATTAAA  120 
 
Query  121  ACAGTCAAAACACATATTACGAATATTTTATCAAAGCTGGATGTCAGTGACCGGACGCAG  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  ACAGTCAAAACACATATTACGAATATTTTATCAAAGCTGGATGTCAGTGACCGGACGCAG  180 
 
Query  181  GCGGCGGTGTACGCACACCGAAATCATCTCGTGAATTAG  219 
            ||||||| ||||||||||||||||||||||||||||||| 
Sbjct  181  GCGGCGGCGTACGCACACCGAAATCATCTCGTGAATTAG  219 
 
xii) LiaRC H205A 
WT-LiaRC was used as the template for mutating the histidine residue at position 205, to alanine. 
SGENALPHESLTKRELEILCLIAEGKTNKEIGEELFITIKTVKTHITNILSKLDVSDRT
QAAVYAHRNHLVN 
Histidine mutated to Alanine 
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Score Expect Identities Gaps Strand 
394 bits(213) 8e-115 217/219(99%) 0/219(0%) Plus/Plus 
Query  1    TCAGGTGAAAACGCGCTCCCGCATGAATCGCTTACAAAACGGGAGCTCGAAATACTCTGC  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    TCAGGTGAAAACGCGCTCCCGCATGAATCGCTTACAAAACGGGAGCTCGAAATACTCTGC  60 
 
Query  61   CTGATCGCAGAAGGAAAGACAAACAAAGAAATAGGCGAGGAACTGTTTATTACGATTAAA  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   CTGATCGCAGAAGGAAAGACAAACAAAGAAATAGGCGAGGAACTGTTTATTACGATTAAA  120 
 
Query  121  ACAGTCAAAACACATATTACGAATATTTTATCAAAGCTGGATGTCAGTGACCGGACGCAG  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  ACAGTCAAAACACATATTACGAATATTTTATCAAAGCTGGATGTCAGTGACCGGACGCAG  180 
 
Query  181  GCGGCGGTGTACGCACACCGAAATCATCTCGTGAATTAG  219 
            |||||||||||||||  |||||||||||||||||||||| 
Sbjct  181  GCGGCGGTGTACGCAGCCCGAAATCATCTCGTGAATTAG  219 
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Appendix B: Band intensity of phosphorylated response regulators, via phosphotransfer 
reactions, were quantified using ImageJ and plotted against time. The data were fitted using 
GraFit software to pseudo first order equation to calculate rate constant. 
i) Phosphotransfer reaction between GST-VraS to LiaR 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 124 
 
ii) Phosphotransfer reaction between GST-LiaS to VraR 
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Appendix C: Quantification of DNase I footprinting data for WT-LiaR and D54A 
Percentage of protected DNA is plotted against protein concentration. The intensity of three to 
four most prominent bands in the protected regions were measured by ImageJ software and 
averaged them out to calculate the protected DNA percentage.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
10
20
30
40
50
60
70
80
90
100
0 2 4 6 8 10 12 14 16
%
 o
f 
P
ro
te
ct
io
n
Protein Concentration (µM)
DNase1 Footprinting Data Quantification 
WT-LiaR WT-LiaR-P LiaR D54A LiaR D54A-P
 126 
 
Appendix D: Crystal structure of LiaR C-Terminus from E. faecalis, modified through 
PyMOL software to show residues interacting amino acids 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Threonine Isoleucine 
Conserved sites of LiaR 
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Appendix E: Sequence alignment of LiaR from Enterococcus faecalis and Bacillus subtilis to 
identify the conserved sites on the C-terminal, bolded and colored here. 
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Appendix F: List of Primers 
Underlined bases represent the restriction sites and the italicized and bolded sequences represent 
the mutated amino acids 
 
 
 
 
 
 
